company_name,company_ticker,company_lei,company_cik,year,quarter,start_date,end_date,filing_date,parent,tag,financial_name,factor,balance,unit,value
Tetraphase Pharmaceuticals Inc,TTPH,,0001373707,2012.0,Q1,2012-01-01,2012-03-31,2013-05-13 16:07:35+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,507000.0
Tetraphase Pharmaceuticals Inc,TTPH,,0001373707,2012.0,Q1,2012-01-01,2012-03-31,2013-05-13 16:07:35+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,507000.0
Tetraphase Pharmaceuticals Inc,TTPH,,0001373707,2012.0,Q1,2012-01-01,2012-03-31,2013-05-13 16:07:35+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,507000.0
Tetraphase Pharmaceuticals Inc,TTPH,,0001373707,2012.0,Q1,2012-01-01,2012-03-31,2013-05-13 16:07:35+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,961000.0
Tetraphase Pharmaceuticals Inc,TTPH,,0001373707,2012.0,Q1,2012-01-01,2012-03-31,2013-05-13 16:07:35+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,4001000.0
Tetraphase Pharmaceuticals Inc,TTPH,,0001373707,2012.0,Q1,2012-01-01,2012-03-31,2013-05-13 16:07:35+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,4962000.0
Tetraphase Pharmaceuticals Inc,TTPH,,0001373707,2012.0,Q1,2012-01-01,2012-03-31,2013-05-13 16:07:35+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-4455000.0
Tetraphase Pharmaceuticals Inc,TTPH,,0001373707,2012.0,Q1,2012-01-01,2012-03-31,2013-05-13 16:07:35+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,234000.0
Tetraphase Pharmaceuticals Inc,TTPH,,0001373707,2012.0,Q1,2012-01-01,2012-03-31,2013-05-13 16:07:35+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-234000.0
Tetraphase Pharmaceuticals Inc,TTPH,,0001373707,2012.0,Q1,2012-01-01,2012-03-31,2013-05-13 16:07:35+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-4689000.0
Tetraphase Pharmaceuticals Inc,TTPH,,0001373707,2012.0,Q1,2012-01-01,2012-03-31,2013-05-13 16:07:35+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-4689000.0
Tetraphase Pharmaceuticals Inc,TTPH,,0001373707,2012.0,Q1,2012-01-01,2012-03-31,2013-05-13 16:07:35+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-4689000.0
Tetraphase Pharmaceuticals Inc,TTPH,,0001373707,2012.0,Q1,2012-01-01,2012-03-31,2013-05-13 16:07:35+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-4689000.0
Tetraphase Pharmaceuticals Inc,TTPH,,0001373707,2012.0,Q1,2012-01-01,2012-03-31,2013-05-13 16:07:35+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,9000000.0
Tetraphase Pharmaceuticals Inc,TTPH,,0001373707,2012.0,Q1,2012-01-01,2012-03-31,2013-05-13 16:07:35+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.52
Tetraphase Pharmaceuticals Inc,TTPH,,0001373707,2012.0,Q1,2012-01-01,2012-03-31,2013-05-13 16:07:35+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,9000000.0
Tetraphase Pharmaceuticals Inc,TTPH,,0001373707,2012.0,Q1,2012-01-01,2012-03-31,2013-05-13 16:07:35+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.52
Tetraphase Pharmaceuticals Inc,TTPH,,0001373707,2012.0,Q1,2012-01-01,2012-03-31,2013-05-13 16:07:35+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,8938399.0
Tetraphase Pharmaceuticals Inc,TTPH,,0001373707,2012.0,Q1,2012-01-01,2012-03-31,2013-05-13 16:07:35+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.52
Tetraphase Pharmaceuticals Inc,TTPH,,0001373707,2012.0,Q2,2012-04-01,2012-06-30,2013-08-12 16:39:50+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,1316000.0
Tetraphase Pharmaceuticals Inc,TTPH,,0001373707,2012.0,Q2,2012-04-01,2012-06-30,2013-08-12 16:39:50+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,1316000.0
Tetraphase Pharmaceuticals Inc,TTPH,,0001373707,2012.0,Q2,2012-04-01,2012-06-30,2013-08-12 16:39:50+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,1316000.0
Tetraphase Pharmaceuticals Inc,TTPH,,0001373707,2012.0,Q2,2012-04-01,2012-06-30,2013-08-12 16:39:50+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,1002000.0
Tetraphase Pharmaceuticals Inc,TTPH,,0001373707,2012.0,Q2,2012-04-01,2012-06-30,2013-08-12 16:39:50+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,4261000.0
Tetraphase Pharmaceuticals Inc,TTPH,,0001373707,2012.0,Q2,2012-04-01,2012-06-30,2013-08-12 16:39:50+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,5263000.0
Tetraphase Pharmaceuticals Inc,TTPH,,0001373707,2012.0,Q2,2012-04-01,2012-06-30,2013-08-12 16:39:50+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-3947000.0
Tetraphase Pharmaceuticals Inc,TTPH,,0001373707,2012.0,Q2,2012-04-01,2012-06-30,2013-08-12 16:39:50+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,216000.0
Tetraphase Pharmaceuticals Inc,TTPH,,0001373707,2012.0,Q2,2012-04-01,2012-06-30,2013-08-12 16:39:50+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-105000.0
Tetraphase Pharmaceuticals Inc,TTPH,,0001373707,2012.0,Q2,2012-04-01,2012-06-30,2013-08-12 16:39:50+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-321000.0
Tetraphase Pharmaceuticals Inc,TTPH,,0001373707,2012.0,Q2,2012-04-01,2012-06-30,2013-08-12 16:39:50+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-4268000.0
Tetraphase Pharmaceuticals Inc,TTPH,,0001373707,2012.0,Q2,2012-04-01,2012-06-30,2013-08-12 16:39:50+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-4268000.0
Tetraphase Pharmaceuticals Inc,TTPH,,0001373707,2012.0,Q2,2012-04-01,2012-06-30,2013-08-12 16:39:50+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-4268000.0
Tetraphase Pharmaceuticals Inc,TTPH,,0001373707,2012.0,Q2,2012-04-01,2012-06-30,2013-08-12 16:39:50+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-4268000.0
Tetraphase Pharmaceuticals Inc,TTPH,,0001373707,2012.0,Q2,2012-04-01,2012-06-30,2013-08-12 16:39:50+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,300000.0
Tetraphase Pharmaceuticals Inc,TTPH,,0001373707,2012.0,Q2,2012-04-01,2012-06-30,2013-08-12 16:39:50+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-13.42
Tetraphase Pharmaceuticals Inc,TTPH,,0001373707,2012.0,Q2,2012-04-01,2012-06-30,2013-08-12 16:39:50+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,300000.0
Tetraphase Pharmaceuticals Inc,TTPH,,0001373707,2012.0,Q2,2012-04-01,2012-06-30,2013-08-12 16:39:50+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-13.42
Tetraphase Pharmaceuticals Inc,TTPH,,0001373707,2012.0,Q2,2012-04-01,2012-06-30,2013-08-12 16:39:50+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,318000.0
Tetraphase Pharmaceuticals Inc,TTPH,,0001373707,2012.0,Q2,2012-04-01,2012-06-30,2013-08-12 16:39:50+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-13.42
Tetraphase Pharmaceuticals Inc,TTPH,,0001373707,2012.0,Q3,2012-07-01,2012-09-30,2013-11-14 06:08:52+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,2537000.0
Tetraphase Pharmaceuticals Inc,TTPH,,0001373707,2012.0,Q3,2012-07-01,2012-09-30,2013-11-14 06:08:52+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,2537000.0
Tetraphase Pharmaceuticals Inc,TTPH,,0001373707,2012.0,Q3,2012-07-01,2012-09-30,2013-11-14 06:08:52+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,2537000.0
Tetraphase Pharmaceuticals Inc,TTPH,,0001373707,2012.0,Q3,2012-07-01,2012-09-30,2013-11-14 06:08:52+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,1017000.0
Tetraphase Pharmaceuticals Inc,TTPH,,0001373707,2012.0,Q3,2012-07-01,2012-09-30,2013-11-14 06:08:52+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,4419000.0
Tetraphase Pharmaceuticals Inc,TTPH,,0001373707,2012.0,Q3,2012-07-01,2012-09-30,2013-11-14 06:08:52+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,5436000.0
Tetraphase Pharmaceuticals Inc,TTPH,,0001373707,2012.0,Q3,2012-07-01,2012-09-30,2013-11-14 06:08:52+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-2899000.0
Tetraphase Pharmaceuticals Inc,TTPH,,0001373707,2012.0,Q3,2012-07-01,2012-09-30,2013-11-14 06:08:52+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,202000.0
Tetraphase Pharmaceuticals Inc,TTPH,,0001373707,2012.0,Q3,2012-07-01,2012-09-30,2013-11-14 06:08:52+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,23000.0
Tetraphase Pharmaceuticals Inc,TTPH,,0001373707,2012.0,Q3,2012-07-01,2012-09-30,2013-11-14 06:08:52+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-179000.0
Tetraphase Pharmaceuticals Inc,TTPH,,0001373707,2012.0,Q3,2012-07-01,2012-09-30,2013-11-14 06:08:52+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-3078000.0
Tetraphase Pharmaceuticals Inc,TTPH,,0001373707,2012.0,Q3,2012-07-01,2012-09-30,2013-11-14 06:08:52+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-3078000.0
Tetraphase Pharmaceuticals Inc,TTPH,,0001373707,2012.0,Q3,2012-07-01,2012-09-30,2013-11-14 06:08:52+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-3078000.0
Tetraphase Pharmaceuticals Inc,TTPH,,0001373707,2012.0,Q3,2012-07-01,2012-09-30,2013-11-14 06:08:52+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-3078000.0
Tetraphase Pharmaceuticals Inc,TTPH,,0001373707,2012.0,Q3,2012-07-01,2012-09-30,2013-11-14 06:08:52+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,300000.0
Tetraphase Pharmaceuticals Inc,TTPH,,0001373707,2012.0,Q3,2012-07-01,2012-09-30,2013-11-14 06:08:52+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-9.63
Tetraphase Pharmaceuticals Inc,TTPH,,0001373707,2012.0,Q3,2012-07-01,2012-09-30,2013-11-14 06:08:52+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,300000.0
Tetraphase Pharmaceuticals Inc,TTPH,,0001373707,2012.0,Q3,2012-07-01,2012-09-30,2013-11-14 06:08:52+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-9.63
Tetraphase Pharmaceuticals Inc,TTPH,,0001373707,2012.0,Q3,2012-07-01,2012-09-30,2013-11-14 06:08:52+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,320000.0
Tetraphase Pharmaceuticals Inc,TTPH,,0001373707,2012.0,Q3,2012-07-01,2012-09-30,2013-11-14 06:08:52+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-9.63
Tetraphase Pharmaceuticals Inc,TTPH,,0001373707,2012.0,Q4,2012-10-01,2012-12-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,3240000.0
Tetraphase Pharmaceuticals Inc,TTPH,,0001373707,2012.0,Q4,2012-10-01,2012-12-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,3240000.0
Tetraphase Pharmaceuticals Inc,TTPH,,0001373707,2012.0,Q4,2012-10-01,2012-12-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,3240000.0
Tetraphase Pharmaceuticals Inc,TTPH,,0001373707,2012.0,Q4,2012-10-01,2012-12-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,1329000.0
Tetraphase Pharmaceuticals Inc,TTPH,,0001373707,2012.0,Q4,2012-10-01,2012-12-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,4613000.0
Tetraphase Pharmaceuticals Inc,TTPH,,0001373707,2012.0,Q4,2012-10-01,2012-12-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,5942000.0
Tetraphase Pharmaceuticals Inc,TTPH,,0001373707,2012.0,Q4,2012-10-01,2012-12-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-2702000.0
Tetraphase Pharmaceuticals Inc,TTPH,,0001373707,2012.0,Q4,2012-10-01,2012-12-31,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,369000.0
Tetraphase Pharmaceuticals Inc,TTPH,,0001373707,2012.0,Q4,2012-10-01,2012-12-31,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,19000.0
Tetraphase Pharmaceuticals Inc,TTPH,,0001373707,2012.0,Q4,2012-10-01,2012-12-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-350000.0
Tetraphase Pharmaceuticals Inc,TTPH,,0001373707,2012.0,Q4,2012-10-01,2012-12-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-3052000.0
Tetraphase Pharmaceuticals Inc,TTPH,,0001373707,2012.0,Q4,2012-10-01,2012-12-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-3052000.0
Tetraphase Pharmaceuticals Inc,TTPH,,0001373707,2012.0,Q4,2012-10-01,2012-12-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-3052000.0
Tetraphase Pharmaceuticals Inc,TTPH,,0001373707,2012.0,Q4,2012-10-01,2012-12-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-3052000.0
Tetraphase Pharmaceuticals Inc,TTPH,,0001373707,2012.0,Q4,2012-10-01,2012-12-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,300000.0
Tetraphase Pharmaceuticals Inc,TTPH,,0001373707,2012.0,Q4,2012-10-01,2012-12-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,-23.97
Tetraphase Pharmaceuticals Inc,TTPH,,0001373707,2012.0,Q4,2012-10-01,2012-12-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,300000.0
Tetraphase Pharmaceuticals Inc,TTPH,,0001373707,2012.0,Q4,2012-10-01,2012-12-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-23.97
Tetraphase Pharmaceuticals Inc,TTPH,,0001373707,2012.0,Q4,2012-10-01,2012-12-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,317000.0
Tetraphase Pharmaceuticals Inc,TTPH,,0001373707,2012.0,Q4,2012-10-01,2012-12-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-23.97
Tetraphase Pharmaceuticals Inc,TTPH,,0001373707,2013.0,Q1,2013-01-01,2013-03-31,2014-05-12 08:20:51+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,2700000.0
Tetraphase Pharmaceuticals Inc,TTPH,,0001373707,2013.0,Q1,2013-01-01,2013-03-31,2014-05-12 08:20:51+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,2700000.0
Tetraphase Pharmaceuticals Inc,TTPH,,0001373707,2013.0,Q1,2013-01-01,2013-03-31,2014-05-12 08:20:51+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,2700000.0
Tetraphase Pharmaceuticals Inc,TTPH,,0001373707,2013.0,Q1,2013-01-01,2013-03-31,2014-05-12 08:20:51+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,1225000.0
Tetraphase Pharmaceuticals Inc,TTPH,,0001373707,2013.0,Q1,2013-01-01,2013-03-31,2014-05-12 08:20:51+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,4098000.0
Tetraphase Pharmaceuticals Inc,TTPH,,0001373707,2013.0,Q1,2013-01-01,2013-03-31,2014-05-12 08:20:51+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,5323000.0
Tetraphase Pharmaceuticals Inc,TTPH,,0001373707,2013.0,Q1,2013-01-01,2013-03-31,2014-05-12 08:20:51+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-2623000.0
Tetraphase Pharmaceuticals Inc,TTPH,,0001373707,2013.0,Q1,2013-01-01,2013-03-31,2014-05-12 08:20:51+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,431000.0
Tetraphase Pharmaceuticals Inc,TTPH,,0001373707,2013.0,Q1,2013-01-01,2013-03-31,2014-05-12 08:20:51+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,263000.0
Tetraphase Pharmaceuticals Inc,TTPH,,0001373707,2013.0,Q1,2013-01-01,2013-03-31,2014-05-12 08:20:51+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-168000.0
Tetraphase Pharmaceuticals Inc,TTPH,,0001373707,2013.0,Q1,2013-01-01,2013-03-31,2014-05-12 08:20:51+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-2791000.0
Tetraphase Pharmaceuticals Inc,TTPH,,0001373707,2013.0,Q1,2013-01-01,2013-03-31,2014-05-12 08:20:51+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-2791000.0
Tetraphase Pharmaceuticals Inc,TTPH,,0001373707,2013.0,Q1,2013-01-01,2013-03-31,2014-05-12 08:20:51+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-2791000.0
Tetraphase Pharmaceuticals Inc,TTPH,,0001373707,2013.0,Q1,2013-01-01,2013-03-31,2014-05-12 08:20:51+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-2791000.0
Tetraphase Pharmaceuticals Inc,TTPH,,0001373707,2013.0,Q1,2013-01-01,2013-03-31,2014-05-12 08:20:51+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,1800000.0
Tetraphase Pharmaceuticals Inc,TTPH,,0001373707,2013.0,Q1,2013-01-01,2013-03-31,2014-05-12 08:20:51+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-1.51
Tetraphase Pharmaceuticals Inc,TTPH,,0001373707,2013.0,Q1,2013-01-01,2013-03-31,2014-05-12 08:20:51+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,1800000.0
Tetraphase Pharmaceuticals Inc,TTPH,,0001373707,2013.0,Q1,2013-01-01,2013-03-31,2014-05-12 08:20:51+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-1.51
Tetraphase Pharmaceuticals Inc,TTPH,,0001373707,2013.0,Q1,2013-01-01,2013-03-31,2014-05-12 08:20:51+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,1848000.0
Tetraphase Pharmaceuticals Inc,TTPH,,0001373707,2013.0,Q1,2013-01-01,2013-03-31,2014-05-12 08:20:51+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-1.51
Tetraphase Pharmaceuticals Inc,TTPH,,0001373707,2013.0,Q2,2013-04-01,2013-06-30,2014-08-12 16:27:21+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,3722000.0
Tetraphase Pharmaceuticals Inc,TTPH,,0001373707,2013.0,Q2,2013-04-01,2013-06-30,2014-08-12 16:27:21+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,3722000.0
Tetraphase Pharmaceuticals Inc,TTPH,,0001373707,2013.0,Q2,2013-04-01,2013-06-30,2014-08-12 16:27:21+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,3722000.0
Tetraphase Pharmaceuticals Inc,TTPH,,0001373707,2013.0,Q2,2013-04-01,2013-06-30,2014-08-12 16:27:21+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,1756000.0
Tetraphase Pharmaceuticals Inc,TTPH,,0001373707,2013.0,Q2,2013-04-01,2013-06-30,2014-08-12 16:27:21+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,6924000.0
Tetraphase Pharmaceuticals Inc,TTPH,,0001373707,2013.0,Q2,2013-04-01,2013-06-30,2014-08-12 16:27:21+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,8680000.0
Tetraphase Pharmaceuticals Inc,TTPH,,0001373707,2013.0,Q2,2013-04-01,2013-06-30,2014-08-12 16:27:21+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-4958000.0
Tetraphase Pharmaceuticals Inc,TTPH,,0001373707,2013.0,Q2,2013-04-01,2013-06-30,2014-08-12 16:27:21+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,470000.0
Tetraphase Pharmaceuticals Inc,TTPH,,0001373707,2013.0,Q2,2013-04-01,2013-06-30,2014-08-12 16:27:21+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,2000.0
Tetraphase Pharmaceuticals Inc,TTPH,,0001373707,2013.0,Q2,2013-04-01,2013-06-30,2014-08-12 16:27:21+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-468000.0
Tetraphase Pharmaceuticals Inc,TTPH,,0001373707,2013.0,Q2,2013-04-01,2013-06-30,2014-08-12 16:27:21+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-5426000.0
Tetraphase Pharmaceuticals Inc,TTPH,,0001373707,2013.0,Q2,2013-04-01,2013-06-30,2014-08-12 16:27:21+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-5426000.0
Tetraphase Pharmaceuticals Inc,TTPH,,0001373707,2013.0,Q2,2013-04-01,2013-06-30,2014-08-12 16:27:21+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-5426000.0
Tetraphase Pharmaceuticals Inc,TTPH,,0001373707,2013.0,Q2,2013-04-01,2013-06-30,2014-08-12 16:27:21+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-5426000.0
Tetraphase Pharmaceuticals Inc,TTPH,,0001373707,2013.0,Q2,2013-04-01,2013-06-30,2014-08-12 16:27:21+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,20900000.0
Tetraphase Pharmaceuticals Inc,TTPH,,0001373707,2013.0,Q2,2013-04-01,2013-06-30,2014-08-12 16:27:21+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.26
Tetraphase Pharmaceuticals Inc,TTPH,,0001373707,2013.0,Q2,2013-04-01,2013-06-30,2014-08-12 16:27:21+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,20900000.0
Tetraphase Pharmaceuticals Inc,TTPH,,0001373707,2013.0,Q2,2013-04-01,2013-06-30,2014-08-12 16:27:21+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.26
Tetraphase Pharmaceuticals Inc,TTPH,,0001373707,2013.0,Q2,2013-04-01,2013-06-30,2014-08-12 16:27:21+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,20575000.0
Tetraphase Pharmaceuticals Inc,TTPH,,0001373707,2013.0,Q2,2013-04-01,2013-06-30,2014-08-12 16:27:21+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.26
Tetraphase Pharmaceuticals Inc,TTPH,,0001373707,2013.0,Q3,2013-07-01,2013-09-30,2014-11-10 16:21:27+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,2166000.0
Tetraphase Pharmaceuticals Inc,TTPH,,0001373707,2013.0,Q3,2013-07-01,2013-09-30,2014-11-10 16:21:27+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,2166000.0
Tetraphase Pharmaceuticals Inc,TTPH,,0001373707,2013.0,Q3,2013-07-01,2013-09-30,2014-11-10 16:21:27+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,2166000.0
Tetraphase Pharmaceuticals Inc,TTPH,,0001373707,2013.0,Q3,2013-07-01,2013-09-30,2014-11-10 16:21:27+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,1860000.0
Tetraphase Pharmaceuticals Inc,TTPH,,0001373707,2013.0,Q3,2013-07-01,2013-09-30,2014-11-10 16:21:27+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,9992000.0
Tetraphase Pharmaceuticals Inc,TTPH,,0001373707,2013.0,Q3,2013-07-01,2013-09-30,2014-11-10 16:21:27+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,11852000.0
Tetraphase Pharmaceuticals Inc,TTPH,,0001373707,2013.0,Q3,2013-07-01,2013-09-30,2014-11-10 16:21:27+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-9686000.0
Tetraphase Pharmaceuticals Inc,TTPH,,0001373707,2013.0,Q3,2013-07-01,2013-09-30,2014-11-10 16:21:27+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,433000.0
Tetraphase Pharmaceuticals Inc,TTPH,,0001373707,2013.0,Q3,2013-07-01,2013-09-30,2014-11-10 16:21:27+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,3000.0
Tetraphase Pharmaceuticals Inc,TTPH,,0001373707,2013.0,Q3,2013-07-01,2013-09-30,2014-11-10 16:21:27+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-430000.0
Tetraphase Pharmaceuticals Inc,TTPH,,0001373707,2013.0,Q3,2013-07-01,2013-09-30,2014-11-10 16:21:27+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-10116000.0
Tetraphase Pharmaceuticals Inc,TTPH,,0001373707,2013.0,Q3,2013-07-01,2013-09-30,2014-11-10 16:21:27+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-10116000.0
Tetraphase Pharmaceuticals Inc,TTPH,,0001373707,2013.0,Q3,2013-07-01,2013-09-30,2014-11-10 16:21:27+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-10116000.0
Tetraphase Pharmaceuticals Inc,TTPH,,0001373707,2013.0,Q3,2013-07-01,2013-09-30,2014-11-10 16:21:27+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-10116000.0
Tetraphase Pharmaceuticals Inc,TTPH,,0001373707,2013.0,Q3,2013-07-01,2013-09-30,2014-11-10 16:21:27+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,20600000.0
Tetraphase Pharmaceuticals Inc,TTPH,,0001373707,2013.0,Q3,2013-07-01,2013-09-30,2014-11-10 16:21:27+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.49
Tetraphase Pharmaceuticals Inc,TTPH,,0001373707,2013.0,Q3,2013-07-01,2013-09-30,2014-11-10 16:21:27+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,20600000.0
Tetraphase Pharmaceuticals Inc,TTPH,,0001373707,2013.0,Q3,2013-07-01,2013-09-30,2014-11-10 16:21:27+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.49
Tetraphase Pharmaceuticals Inc,TTPH,,0001373707,2013.0,Q3,2013-07-01,2013-09-30,2014-11-10 16:21:27+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,20674000.0
Tetraphase Pharmaceuticals Inc,TTPH,,0001373707,2013.0,Q3,2013-07-01,2013-09-30,2014-11-10 16:21:27+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.49
Tetraphase Pharmaceuticals Inc,TTPH,,0001373707,2013.0,Q4,2013-10-01,2013-12-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,1898000.0
Tetraphase Pharmaceuticals Inc,TTPH,,0001373707,2013.0,Q4,2013-10-01,2013-12-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,1898000.0
Tetraphase Pharmaceuticals Inc,TTPH,,0001373707,2013.0,Q4,2013-10-01,2013-12-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,1898000.0
Tetraphase Pharmaceuticals Inc,TTPH,,0001373707,2013.0,Q4,2013-10-01,2013-12-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,2327000.0
Tetraphase Pharmaceuticals Inc,TTPH,,0001373707,2013.0,Q4,2013-10-01,2013-12-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,10494000.0
Tetraphase Pharmaceuticals Inc,TTPH,,0001373707,2013.0,Q4,2013-10-01,2013-12-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,12821000.0
Tetraphase Pharmaceuticals Inc,TTPH,,0001373707,2013.0,Q4,2013-10-01,2013-12-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-10923000.0
Tetraphase Pharmaceuticals Inc,TTPH,,0001373707,2013.0,Q4,2013-10-01,2013-12-31,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,385000.0
Tetraphase Pharmaceuticals Inc,TTPH,,0001373707,2013.0,Q4,2013-10-01,2013-12-31,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,5000.0
Tetraphase Pharmaceuticals Inc,TTPH,,0001373707,2013.0,Q4,2013-10-01,2013-12-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-380000.0
Tetraphase Pharmaceuticals Inc,TTPH,,0001373707,2013.0,Q4,2013-10-01,2013-12-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-11303000.0
Tetraphase Pharmaceuticals Inc,TTPH,,0001373707,2013.0,Q4,2013-10-01,2013-12-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-11303000.0
Tetraphase Pharmaceuticals Inc,TTPH,,0001373707,2013.0,Q4,2013-10-01,2013-12-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-11303000.0
Tetraphase Pharmaceuticals Inc,TTPH,,0001373707,2013.0,Q4,2013-10-01,2013-12-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-11303000.0
Tetraphase Pharmaceuticals Inc,TTPH,,0001373707,2013.0,Q4,2013-10-01,2013-12-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,16600000.0
Tetraphase Pharmaceuticals Inc,TTPH,,0001373707,2013.0,Q4,2013-10-01,2013-12-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,0.48
Tetraphase Pharmaceuticals Inc,TTPH,,0001373707,2013.0,Q4,2013-10-01,2013-12-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,16600000.0
Tetraphase Pharmaceuticals Inc,TTPH,,0001373707,2013.0,Q4,2013-10-01,2013-12-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.48
Tetraphase Pharmaceuticals Inc,TTPH,,0001373707,2013.0,Q4,2013-10-01,2013-12-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,16665000.0
Tetraphase Pharmaceuticals Inc,TTPH,,0001373707,2013.0,Q4,2013-10-01,2013-12-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.48
Tetraphase Pharmaceuticals Inc,TTPH,,0001373707,2014.0,Q1,2014-01-01,2014-03-31,2015-05-07 16:54:49+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,2457000.0
Tetraphase Pharmaceuticals Inc,TTPH,,0001373707,2014.0,Q1,2014-01-01,2014-03-31,2015-05-07 16:54:49+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,2457000.0
Tetraphase Pharmaceuticals Inc,TTPH,,0001373707,2014.0,Q1,2014-01-01,2014-03-31,2015-05-07 16:54:49+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,2457000.0
Tetraphase Pharmaceuticals Inc,TTPH,,0001373707,2014.0,Q1,2014-01-01,2014-03-31,2015-05-07 16:54:49+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,3171000.0
Tetraphase Pharmaceuticals Inc,TTPH,,0001373707,2014.0,Q1,2014-01-01,2014-03-31,2015-05-07 16:54:49+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,12504000.0
Tetraphase Pharmaceuticals Inc,TTPH,,0001373707,2014.0,Q1,2014-01-01,2014-03-31,2015-05-07 16:54:49+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,15675000.0
Tetraphase Pharmaceuticals Inc,TTPH,,0001373707,2014.0,Q1,2014-01-01,2014-03-31,2015-05-07 16:54:49+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-13218000.0
Tetraphase Pharmaceuticals Inc,TTPH,,0001373707,2014.0,Q1,2014-01-01,2014-03-31,2015-05-07 16:54:49+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,334000.0
Tetraphase Pharmaceuticals Inc,TTPH,,0001373707,2014.0,Q1,2014-01-01,2014-03-31,2015-05-07 16:54:49+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,5000.0
Tetraphase Pharmaceuticals Inc,TTPH,,0001373707,2014.0,Q1,2014-01-01,2014-03-31,2015-05-07 16:54:49+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,24000.0
Tetraphase Pharmaceuticals Inc,TTPH,,0001373707,2014.0,Q1,2014-01-01,2014-03-31,2015-05-07 16:54:49+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-305000.0
Tetraphase Pharmaceuticals Inc,TTPH,,0001373707,2014.0,Q1,2014-01-01,2014-03-31,2015-05-07 16:54:49+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-13523000.0
Tetraphase Pharmaceuticals Inc,TTPH,,0001373707,2014.0,Q1,2014-01-01,2014-03-31,2015-05-07 16:54:49+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-13523000.0
Tetraphase Pharmaceuticals Inc,TTPH,,0001373707,2014.0,Q1,2014-01-01,2014-03-31,2015-05-07 16:54:49+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-13523000.0
Tetraphase Pharmaceuticals Inc,TTPH,,0001373707,2014.0,Q1,2014-01-01,2014-03-31,2015-05-07 16:54:49+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-13523000.0
Tetraphase Pharmaceuticals Inc,TTPH,,0001373707,2014.0,Q1,2014-01-01,2014-03-31,2015-05-07 16:54:49+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,25500000.0
Tetraphase Pharmaceuticals Inc,TTPH,,0001373707,2014.0,Q1,2014-01-01,2014-03-31,2015-05-07 16:54:49+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.53
Tetraphase Pharmaceuticals Inc,TTPH,,0001373707,2014.0,Q1,2014-01-01,2014-03-31,2015-05-07 16:54:49+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,25500000.0
Tetraphase Pharmaceuticals Inc,TTPH,,0001373707,2014.0,Q1,2014-01-01,2014-03-31,2015-05-07 16:54:49+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.53
Tetraphase Pharmaceuticals Inc,TTPH,,0001373707,2014.0,Q1,2014-01-01,2014-03-31,2015-05-07 16:54:49+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,25734000.0
Tetraphase Pharmaceuticals Inc,TTPH,,0001373707,2014.0,Q1,2014-01-01,2014-03-31,2015-05-07 16:54:49+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.53
Tetraphase Pharmaceuticals Inc,TTPH,,0001373707,2014.0,Q2,2014-04-01,2014-06-30,2015-08-06 09:23:55+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,1275000.0
Tetraphase Pharmaceuticals Inc,TTPH,,0001373707,2014.0,Q2,2014-04-01,2014-06-30,2015-08-06 09:23:55+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,1275000.0
Tetraphase Pharmaceuticals Inc,TTPH,,0001373707,2014.0,Q2,2014-04-01,2014-06-30,2015-08-06 09:23:55+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,1275000.0
Tetraphase Pharmaceuticals Inc,TTPH,,0001373707,2014.0,Q2,2014-04-01,2014-06-30,2015-08-06 09:23:55+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,2947000.0
Tetraphase Pharmaceuticals Inc,TTPH,,0001373707,2014.0,Q2,2014-04-01,2014-06-30,2015-08-06 09:23:55+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,16513000.0
Tetraphase Pharmaceuticals Inc,TTPH,,0001373707,2014.0,Q2,2014-04-01,2014-06-30,2015-08-06 09:23:55+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,19460000.0
Tetraphase Pharmaceuticals Inc,TTPH,,0001373707,2014.0,Q2,2014-04-01,2014-06-30,2015-08-06 09:23:55+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-18185000.0
Tetraphase Pharmaceuticals Inc,TTPH,,0001373707,2014.0,Q2,2014-04-01,2014-06-30,2015-08-06 09:23:55+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-18185000.0
Tetraphase Pharmaceuticals Inc,TTPH,,0001373707,2014.0,Q2,2014-04-01,2014-06-30,2015-08-06 09:23:55+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-18185000.0
Tetraphase Pharmaceuticals Inc,TTPH,,0001373707,2014.0,Q2,2014-04-01,2014-06-30,2015-08-06 09:23:55+00:00,netincome,otheradjustmentstoconsolidatednetincome,Other Adjustments to Consolidated Net Income / (Loss),+,credit,usd,-278000.0
Tetraphase Pharmaceuticals Inc,TTPH,,0001373707,2014.0,Q2,2014-04-01,2014-06-30,2015-08-06 09:23:55+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-18463000.0
Tetraphase Pharmaceuticals Inc,TTPH,,0001373707,2014.0,Q2,2014-04-01,2014-06-30,2015-08-06 09:23:55+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-18463000.0
Tetraphase Pharmaceuticals Inc,TTPH,,0001373707,2014.0,Q2,2014-04-01,2014-06-30,2015-08-06 09:23:55+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,26000000.0
Tetraphase Pharmaceuticals Inc,TTPH,,0001373707,2014.0,Q2,2014-04-01,2014-06-30,2015-08-06 09:23:55+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.71
Tetraphase Pharmaceuticals Inc,TTPH,,0001373707,2014.0,Q2,2014-04-01,2014-06-30,2015-08-06 09:23:55+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,26000000.0
Tetraphase Pharmaceuticals Inc,TTPH,,0001373707,2014.0,Q2,2014-04-01,2014-06-30,2015-08-06 09:23:55+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.71
Tetraphase Pharmaceuticals Inc,TTPH,,0001373707,2014.0,Q2,2014-04-01,2014-06-30,2015-08-06 09:23:55+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,25845000.0
Tetraphase Pharmaceuticals Inc,TTPH,,0001373707,2014.0,Q2,2014-04-01,2014-06-30,2015-08-06 09:23:55+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.71
Tetraphase Pharmaceuticals Inc,TTPH,,0001373707,2014.0,Q3,2014-06-24,2014-09-30,2015-11-02 09:17:45+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,2294000.0
Tetraphase Pharmaceuticals Inc,TTPH,,0001373707,2014.0,Q3,2014-06-24,2014-09-30,2015-11-02 09:17:45+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,2294000.0
Tetraphase Pharmaceuticals Inc,TTPH,,0001373707,2014.0,Q3,2014-06-24,2014-09-30,2015-11-02 09:17:45+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,2294000.0
Tetraphase Pharmaceuticals Inc,TTPH,,0001373707,2014.0,Q3,2014-06-24,2014-09-30,2015-11-02 09:17:45+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,3086000.0
Tetraphase Pharmaceuticals Inc,TTPH,,0001373707,2014.0,Q3,2014-06-24,2014-09-30,2015-11-02 09:17:45+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,13188000.0
Tetraphase Pharmaceuticals Inc,TTPH,,0001373707,2014.0,Q3,2014-06-24,2014-09-30,2015-11-02 09:17:45+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,16274000.0
Tetraphase Pharmaceuticals Inc,TTPH,,0001373707,2014.0,Q3,2014-06-24,2014-09-30,2015-11-02 09:17:45+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-13980000.0
Tetraphase Pharmaceuticals Inc,TTPH,,0001373707,2014.0,Q3,2014-06-24,2014-09-30,2015-11-02 09:17:45+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-13980000.0
Tetraphase Pharmaceuticals Inc,TTPH,,0001373707,2014.0,Q3,2014-06-24,2014-09-30,2015-11-02 09:17:45+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-13980000.0
Tetraphase Pharmaceuticals Inc,TTPH,,0001373707,2014.0,Q3,2014-06-24,2014-09-30,2015-11-02 09:17:45+00:00,netincome,otheradjustmentstoconsolidatednetincome,Other Adjustments to Consolidated Net Income / (Loss),+,credit,usd,-226000.0
Tetraphase Pharmaceuticals Inc,TTPH,,0001373707,2014.0,Q3,2014-06-24,2014-09-30,2015-11-02 09:17:45+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-14206000.0
Tetraphase Pharmaceuticals Inc,TTPH,,0001373707,2014.0,Q3,2014-06-24,2014-09-30,2015-11-02 09:17:45+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-14206000.0
Tetraphase Pharmaceuticals Inc,TTPH,,0001373707,2014.0,Q3,2014-06-24,2014-09-30,2015-11-02 09:17:45+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,25800000.0
Tetraphase Pharmaceuticals Inc,TTPH,,0001373707,2014.0,Q3,2014-06-24,2014-09-30,2015-11-02 09:17:45+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.55
Tetraphase Pharmaceuticals Inc,TTPH,,0001373707,2014.0,Q3,2014-06-24,2014-09-30,2015-11-02 09:17:45+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,25800000.0
Tetraphase Pharmaceuticals Inc,TTPH,,0001373707,2014.0,Q3,2014-06-24,2014-09-30,2015-11-02 09:17:45+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.55
Tetraphase Pharmaceuticals Inc,TTPH,,0001373707,2014.0,Q3,2014-06-24,2014-09-30,2015-11-02 09:17:45+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,25967000.0
Tetraphase Pharmaceuticals Inc,TTPH,,0001373707,2014.0,Q3,2014-06-24,2014-09-30,2015-11-02 09:17:45+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.55
Tetraphase Pharmaceuticals Inc,TTPH,,0001373707,2014.0,Q4,2014-10-01,2014-12-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,3072000.0
Tetraphase Pharmaceuticals Inc,TTPH,,0001373707,2014.0,Q4,2014-10-01,2014-12-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,3072000.0
Tetraphase Pharmaceuticals Inc,TTPH,,0001373707,2014.0,Q4,2014-10-01,2014-12-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,3072000.0
Tetraphase Pharmaceuticals Inc,TTPH,,0001373707,2014.0,Q4,2014-10-01,2014-12-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,3728000.0
Tetraphase Pharmaceuticals Inc,TTPH,,0001373707,2014.0,Q4,2014-10-01,2014-12-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,19727000.0
Tetraphase Pharmaceuticals Inc,TTPH,,0001373707,2014.0,Q4,2014-10-01,2014-12-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,23455000.0
Tetraphase Pharmaceuticals Inc,TTPH,,0001373707,2014.0,Q4,2014-10-01,2014-12-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-20383000.0
Tetraphase Pharmaceuticals Inc,TTPH,,0001373707,2014.0,Q4,2014-10-01,2014-12-31,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,683000.0
Tetraphase Pharmaceuticals Inc,TTPH,,0001373707,2014.0,Q4,2014-10-01,2014-12-31,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,12000.0
Tetraphase Pharmaceuticals Inc,TTPH,,0001373707,2014.0,Q4,2014-10-01,2014-12-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-671000.0
Tetraphase Pharmaceuticals Inc,TTPH,,0001373707,2014.0,Q4,2014-10-01,2014-12-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-21054000.0
Tetraphase Pharmaceuticals Inc,TTPH,,0001373707,2014.0,Q4,2014-10-01,2014-12-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-21054000.0
Tetraphase Pharmaceuticals Inc,TTPH,,0001373707,2014.0,Q4,2014-10-01,2014-12-31,,netincome,otheradjustmentstoconsolidatednetincome,Other Adjustments to Consolidated Net Income / (Loss),+,credit,usd,504000.0
Tetraphase Pharmaceuticals Inc,TTPH,,0001373707,2014.0,Q4,2014-10-01,2014-12-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-20550000.0
Tetraphase Pharmaceuticals Inc,TTPH,,0001373707,2014.0,Q4,2014-10-01,2014-12-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-20550000.0
Tetraphase Pharmaceuticals Inc,TTPH,,0001373707,2014.0,Q4,2014-10-01,2014-12-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,26800000.0
Tetraphase Pharmaceuticals Inc,TTPH,,0001373707,2014.0,Q4,2014-10-01,2014-12-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.7
Tetraphase Pharmaceuticals Inc,TTPH,,0001373707,2014.0,Q4,2014-10-01,2014-12-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,26800000.0
Tetraphase Pharmaceuticals Inc,TTPH,,0001373707,2014.0,Q4,2014-10-01,2014-12-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.7
Tetraphase Pharmaceuticals Inc,TTPH,,0001373707,2014.0,Q4,2014-10-01,2014-12-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,26807000.0
Tetraphase Pharmaceuticals Inc,TTPH,,0001373707,2014.0,Q4,2014-10-01,2014-12-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.7
Tetraphase Pharmaceuticals Inc,TTPH,,0001373707,2015.0,Q1,2015-01-01,2015-03-31,2016-05-04 16:06:13+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,3016000.0
Tetraphase Pharmaceuticals Inc,TTPH,,0001373707,2015.0,Q1,2015-01-01,2015-03-31,2016-05-04 16:06:13+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,3016000.0
Tetraphase Pharmaceuticals Inc,TTPH,,0001373707,2015.0,Q1,2015-01-01,2015-03-31,2016-05-04 16:06:13+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,3016000.0
Tetraphase Pharmaceuticals Inc,TTPH,,0001373707,2015.0,Q1,2015-01-01,2015-03-31,2016-05-04 16:06:13+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,4903000.0
Tetraphase Pharmaceuticals Inc,TTPH,,0001373707,2015.0,Q1,2015-01-01,2015-03-31,2016-05-04 16:06:13+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,18873000.0
Tetraphase Pharmaceuticals Inc,TTPH,,0001373707,2015.0,Q1,2015-01-01,2015-03-31,2016-05-04 16:06:13+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,23776000.0
Tetraphase Pharmaceuticals Inc,TTPH,,0001373707,2015.0,Q1,2015-01-01,2015-03-31,2016-05-04 16:06:13+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-20760000.0
Tetraphase Pharmaceuticals Inc,TTPH,,0001373707,2015.0,Q1,2015-01-01,2015-03-31,2016-05-04 16:06:13+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-226000.0
Tetraphase Pharmaceuticals Inc,TTPH,,0001373707,2015.0,Q1,2015-01-01,2015-03-31,2016-05-04 16:06:13+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-226000.0
Tetraphase Pharmaceuticals Inc,TTPH,,0001373707,2015.0,Q1,2015-01-01,2015-03-31,2016-05-04 16:06:13+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-20986000.0
Tetraphase Pharmaceuticals Inc,TTPH,,0001373707,2015.0,Q1,2015-01-01,2015-03-31,2016-05-04 16:06:13+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-20986000.0
Tetraphase Pharmaceuticals Inc,TTPH,,0001373707,2015.0,Q1,2015-01-01,2015-03-31,2016-05-04 16:06:13+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-20986000.0
Tetraphase Pharmaceuticals Inc,TTPH,,0001373707,2015.0,Q1,2015-01-01,2015-03-31,2016-05-04 16:06:13+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-20986000.0
Tetraphase Pharmaceuticals Inc,TTPH,,0001373707,2015.0,Q1,2015-01-01,2015-03-31,2016-05-04 16:06:13+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,31800000.0
Tetraphase Pharmaceuticals Inc,TTPH,,0001373707,2015.0,Q1,2015-01-01,2015-03-31,2016-05-04 16:06:13+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.66
Tetraphase Pharmaceuticals Inc,TTPH,,0001373707,2015.0,Q1,2015-01-01,2015-03-31,2016-05-04 16:06:13+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,31800000.0
Tetraphase Pharmaceuticals Inc,TTPH,,0001373707,2015.0,Q1,2015-01-01,2015-03-31,2016-05-04 16:06:13+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.66
Tetraphase Pharmaceuticals Inc,TTPH,,0001373707,2015.0,Q1,2015-01-01,2015-03-31,2016-05-04 16:06:13+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,31750000.0
Tetraphase Pharmaceuticals Inc,TTPH,,0001373707,2015.0,Q1,2015-01-01,2015-03-31,2016-05-04 16:06:13+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.66
Tetraphase Pharmaceuticals Inc,TTPH,,0001373707,2015.0,Q2,2015-04-01,2015-06-30,2016-08-04 16:16:16+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,3343000.0
Tetraphase Pharmaceuticals Inc,TTPH,,0001373707,2015.0,Q2,2015-04-01,2015-06-30,2016-08-04 16:16:16+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,3343000.0
Tetraphase Pharmaceuticals Inc,TTPH,,0001373707,2015.0,Q2,2015-04-01,2015-06-30,2016-08-04 16:16:16+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,3343000.0
Tetraphase Pharmaceuticals Inc,TTPH,,0001373707,2015.0,Q2,2015-04-01,2015-06-30,2016-08-04 16:16:16+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,6489000.0
Tetraphase Pharmaceuticals Inc,TTPH,,0001373707,2015.0,Q2,2015-04-01,2015-06-30,2016-08-04 16:16:16+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,22907000.0
Tetraphase Pharmaceuticals Inc,TTPH,,0001373707,2015.0,Q2,2015-04-01,2015-06-30,2016-08-04 16:16:16+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,29396000.0
Tetraphase Pharmaceuticals Inc,TTPH,,0001373707,2015.0,Q2,2015-04-01,2015-06-30,2016-08-04 16:16:16+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-26053000.0
Tetraphase Pharmaceuticals Inc,TTPH,,0001373707,2015.0,Q2,2015-04-01,2015-06-30,2016-08-04 16:16:16+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,10000.0
Tetraphase Pharmaceuticals Inc,TTPH,,0001373707,2015.0,Q2,2015-04-01,2015-06-30,2016-08-04 16:16:16+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,10000.0
Tetraphase Pharmaceuticals Inc,TTPH,,0001373707,2015.0,Q2,2015-04-01,2015-06-30,2016-08-04 16:16:16+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-26043000.0
Tetraphase Pharmaceuticals Inc,TTPH,,0001373707,2015.0,Q2,2015-04-01,2015-06-30,2016-08-04 16:16:16+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-26043000.0
Tetraphase Pharmaceuticals Inc,TTPH,,0001373707,2015.0,Q2,2015-04-01,2015-06-30,2016-08-04 16:16:16+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-26043000.0
Tetraphase Pharmaceuticals Inc,TTPH,,0001373707,2015.0,Q2,2015-04-01,2015-06-30,2016-08-04 16:16:16+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-26043000.0
Tetraphase Pharmaceuticals Inc,TTPH,,0001373707,2015.0,Q2,2015-04-01,2015-06-30,2016-08-04 16:16:16+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,36200000.0
Tetraphase Pharmaceuticals Inc,TTPH,,0001373707,2015.0,Q2,2015-04-01,2015-06-30,2016-08-04 16:16:16+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.72
Tetraphase Pharmaceuticals Inc,TTPH,,0001373707,2015.0,Q2,2015-04-01,2015-06-30,2016-08-04 16:16:16+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,36200000.0
Tetraphase Pharmaceuticals Inc,TTPH,,0001373707,2015.0,Q2,2015-04-01,2015-06-30,2016-08-04 16:16:16+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.72
Tetraphase Pharmaceuticals Inc,TTPH,,0001373707,2015.0,Q2,2015-04-01,2015-06-30,2016-08-04 16:16:16+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,36207000.0
Tetraphase Pharmaceuticals Inc,TTPH,,0001373707,2015.0,Q2,2015-04-01,2015-06-30,2016-08-04 16:16:16+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.72
Tetraphase Pharmaceuticals Inc,TTPH,,0001373707,2015.0,Q3,2015-07-01,2015-09-30,2016-11-03 16:12:16+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,2856000.0
Tetraphase Pharmaceuticals Inc,TTPH,,0001373707,2015.0,Q3,2015-07-01,2015-09-30,2016-11-03 16:12:16+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,2856000.0
Tetraphase Pharmaceuticals Inc,TTPH,,0001373707,2015.0,Q3,2015-07-01,2015-09-30,2016-11-03 16:12:16+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,2856000.0
Tetraphase Pharmaceuticals Inc,TTPH,,0001373707,2015.0,Q3,2015-07-01,2015-09-30,2016-11-03 16:12:16+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,3937000.0
Tetraphase Pharmaceuticals Inc,TTPH,,0001373707,2015.0,Q3,2015-07-01,2015-09-30,2016-11-03 16:12:16+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,16972000.0
Tetraphase Pharmaceuticals Inc,TTPH,,0001373707,2015.0,Q3,2015-07-01,2015-09-30,2016-11-03 16:12:16+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,20909000.0
Tetraphase Pharmaceuticals Inc,TTPH,,0001373707,2015.0,Q3,2015-07-01,2015-09-30,2016-11-03 16:12:16+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-18053000.0
Tetraphase Pharmaceuticals Inc,TTPH,,0001373707,2015.0,Q3,2015-07-01,2015-09-30,2016-11-03 16:12:16+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,9000.0
Tetraphase Pharmaceuticals Inc,TTPH,,0001373707,2015.0,Q3,2015-07-01,2015-09-30,2016-11-03 16:12:16+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,9000.0
Tetraphase Pharmaceuticals Inc,TTPH,,0001373707,2015.0,Q3,2015-07-01,2015-09-30,2016-11-03 16:12:16+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-18044000.0
Tetraphase Pharmaceuticals Inc,TTPH,,0001373707,2015.0,Q3,2015-07-01,2015-09-30,2016-11-03 16:12:16+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-18044000.0
Tetraphase Pharmaceuticals Inc,TTPH,,0001373707,2015.0,Q3,2015-07-01,2015-09-30,2016-11-03 16:12:16+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-18044000.0
Tetraphase Pharmaceuticals Inc,TTPH,,0001373707,2015.0,Q3,2015-07-01,2015-09-30,2016-11-03 16:12:16+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-18044000.0
Tetraphase Pharmaceuticals Inc,TTPH,,0001373707,2015.0,Q3,2015-07-01,2015-09-30,2016-11-03 16:12:16+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,36800000.0
Tetraphase Pharmaceuticals Inc,TTPH,,0001373707,2015.0,Q3,2015-07-01,2015-09-30,2016-11-03 16:12:16+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.49
Tetraphase Pharmaceuticals Inc,TTPH,,0001373707,2015.0,Q3,2015-07-01,2015-09-30,2016-11-03 16:12:16+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,36800000.0
Tetraphase Pharmaceuticals Inc,TTPH,,0001373707,2015.0,Q3,2015-07-01,2015-09-30,2016-11-03 16:12:16+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.49
Tetraphase Pharmaceuticals Inc,TTPH,,0001373707,2015.0,Q3,2015-07-01,2015-09-30,2016-11-03 16:12:16+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,36463000.0
Tetraphase Pharmaceuticals Inc,TTPH,,0001373707,2015.0,Q3,2015-07-01,2015-09-30,2016-11-03 16:12:16+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.49
Tetraphase Pharmaceuticals Inc,TTPH,,0001373707,2015.0,Q4,2015-10-01,2015-12-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,2471000.0
Tetraphase Pharmaceuticals Inc,TTPH,,0001373707,2015.0,Q4,2015-10-01,2015-12-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,2471000.0
Tetraphase Pharmaceuticals Inc,TTPH,,0001373707,2015.0,Q4,2015-10-01,2015-12-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,2471000.0
Tetraphase Pharmaceuticals Inc,TTPH,,0001373707,2015.0,Q4,2015-10-01,2015-12-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,5587000.0
Tetraphase Pharmaceuticals Inc,TTPH,,0001373707,2015.0,Q4,2015-10-01,2015-12-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,15016000.0
Tetraphase Pharmaceuticals Inc,TTPH,,0001373707,2015.0,Q4,2015-10-01,2015-12-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,20603000.0
Tetraphase Pharmaceuticals Inc,TTPH,,0001373707,2015.0,Q4,2015-10-01,2015-12-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-18132000.0
Tetraphase Pharmaceuticals Inc,TTPH,,0001373707,2015.0,Q4,2015-10-01,2015-12-31,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,16000.0
Tetraphase Pharmaceuticals Inc,TTPH,,0001373707,2015.0,Q4,2015-10-01,2015-12-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,16000.0
Tetraphase Pharmaceuticals Inc,TTPH,,0001373707,2015.0,Q4,2015-10-01,2015-12-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-18116000.0
Tetraphase Pharmaceuticals Inc,TTPH,,0001373707,2015.0,Q4,2015-10-01,2015-12-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-18116000.0
Tetraphase Pharmaceuticals Inc,TTPH,,0001373707,2015.0,Q4,2015-10-01,2015-12-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-18116000.0
Tetraphase Pharmaceuticals Inc,TTPH,,0001373707,2015.0,Q4,2015-10-01,2015-12-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-18116000.0
Tetraphase Pharmaceuticals Inc,TTPH,,0001373707,2015.0,Q4,2015-10-01,2015-12-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,35200000.0
Tetraphase Pharmaceuticals Inc,TTPH,,0001373707,2015.0,Q4,2015-10-01,2015-12-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.49
Tetraphase Pharmaceuticals Inc,TTPH,,0001373707,2015.0,Q4,2015-10-01,2015-12-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,35200000.0
Tetraphase Pharmaceuticals Inc,TTPH,,0001373707,2015.0,Q4,2015-10-01,2015-12-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.49
Tetraphase Pharmaceuticals Inc,TTPH,,0001373707,2015.0,Q4,2015-10-01,2015-12-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,35261000.0
Tetraphase Pharmaceuticals Inc,TTPH,,0001373707,2015.0,Q4,2015-10-01,2015-12-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.49
Tetraphase Pharmaceuticals Inc,TTPH,,0001373707,2016.0,Q1,2016-01-01,2016-03-31,2017-05-08 16:19:24+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,1962000.0
Tetraphase Pharmaceuticals Inc,TTPH,,0001373707,2016.0,Q1,2016-01-01,2016-03-31,2017-05-08 16:19:24+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,1962000.0
Tetraphase Pharmaceuticals Inc,TTPH,,0001373707,2016.0,Q1,2016-01-01,2016-03-31,2017-05-08 16:19:24+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,1962000.0
Tetraphase Pharmaceuticals Inc,TTPH,,0001373707,2016.0,Q1,2016-01-01,2016-03-31,2017-05-08 16:19:24+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,5253000.0
Tetraphase Pharmaceuticals Inc,TTPH,,0001373707,2016.0,Q1,2016-01-01,2016-03-31,2017-05-08 16:19:24+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,13523000.0
Tetraphase Pharmaceuticals Inc,TTPH,,0001373707,2016.0,Q1,2016-01-01,2016-03-31,2017-05-08 16:19:24+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,18776000.0
Tetraphase Pharmaceuticals Inc,TTPH,,0001373707,2016.0,Q1,2016-01-01,2016-03-31,2017-05-08 16:19:24+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-16814000.0
Tetraphase Pharmaceuticals Inc,TTPH,,0001373707,2016.0,Q1,2016-01-01,2016-03-31,2017-05-08 16:19:24+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,73000.0
Tetraphase Pharmaceuticals Inc,TTPH,,0001373707,2016.0,Q1,2016-01-01,2016-03-31,2017-05-08 16:19:24+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,73000.0
Tetraphase Pharmaceuticals Inc,TTPH,,0001373707,2016.0,Q1,2016-01-01,2016-03-31,2017-05-08 16:19:24+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-16741000.0
Tetraphase Pharmaceuticals Inc,TTPH,,0001373707,2016.0,Q1,2016-01-01,2016-03-31,2017-05-08 16:19:24+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-16741000.0
Tetraphase Pharmaceuticals Inc,TTPH,,0001373707,2016.0,Q1,2016-01-01,2016-03-31,2017-05-08 16:19:24+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-16741000.0
Tetraphase Pharmaceuticals Inc,TTPH,,0001373707,2016.0,Q1,2016-01-01,2016-03-31,2017-05-08 16:19:24+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-16741000.0
Tetraphase Pharmaceuticals Inc,TTPH,,0001373707,2016.0,Q1,2016-01-01,2016-03-31,2017-05-08 16:19:24+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,36400000.0
Tetraphase Pharmaceuticals Inc,TTPH,,0001373707,2016.0,Q1,2016-01-01,2016-03-31,2017-05-08 16:19:24+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.46
Tetraphase Pharmaceuticals Inc,TTPH,,0001373707,2016.0,Q1,2016-01-01,2016-03-31,2017-05-08 16:19:24+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,36400000.0
Tetraphase Pharmaceuticals Inc,TTPH,,0001373707,2016.0,Q1,2016-01-01,2016-03-31,2017-05-08 16:19:24+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.46
Tetraphase Pharmaceuticals Inc,TTPH,,0001373707,2016.0,Q1,2016-01-01,2016-03-31,2017-05-08 16:19:24+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,36598000.0
Tetraphase Pharmaceuticals Inc,TTPH,,0001373707,2016.0,Q1,2016-01-01,2016-03-31,2017-05-08 16:19:24+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.46
Tetraphase Pharmaceuticals Inc,TTPH,,0001373707,2016.0,Q2,2016-04-01,2016-06-30,2017-08-02 16:06:19+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,1243000.0
Tetraphase Pharmaceuticals Inc,TTPH,,0001373707,2016.0,Q2,2016-04-01,2016-06-30,2017-08-02 16:06:19+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,1243000.0
Tetraphase Pharmaceuticals Inc,TTPH,,0001373707,2016.0,Q2,2016-04-01,2016-06-30,2017-08-02 16:06:19+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,1243000.0
Tetraphase Pharmaceuticals Inc,TTPH,,0001373707,2016.0,Q2,2016-04-01,2016-06-30,2017-08-02 16:06:19+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,4759000.0
Tetraphase Pharmaceuticals Inc,TTPH,,0001373707,2016.0,Q2,2016-04-01,2016-06-30,2017-08-02 16:06:19+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,13746000.0
Tetraphase Pharmaceuticals Inc,TTPH,,0001373707,2016.0,Q2,2016-04-01,2016-06-30,2017-08-02 16:06:19+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,18505000.0
Tetraphase Pharmaceuticals Inc,TTPH,,0001373707,2016.0,Q2,2016-04-01,2016-06-30,2017-08-02 16:06:19+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-17262000.0
Tetraphase Pharmaceuticals Inc,TTPH,,0001373707,2016.0,Q2,2016-04-01,2016-06-30,2017-08-02 16:06:19+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,94000.0
Tetraphase Pharmaceuticals Inc,TTPH,,0001373707,2016.0,Q2,2016-04-01,2016-06-30,2017-08-02 16:06:19+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,94000.0
Tetraphase Pharmaceuticals Inc,TTPH,,0001373707,2016.0,Q2,2016-04-01,2016-06-30,2017-08-02 16:06:19+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-17168000.0
Tetraphase Pharmaceuticals Inc,TTPH,,0001373707,2016.0,Q2,2016-04-01,2016-06-30,2017-08-02 16:06:19+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-17168000.0
Tetraphase Pharmaceuticals Inc,TTPH,,0001373707,2016.0,Q2,2016-04-01,2016-06-30,2017-08-02 16:06:19+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-17168000.0
Tetraphase Pharmaceuticals Inc,TTPH,,0001373707,2016.0,Q2,2016-04-01,2016-06-30,2017-08-02 16:06:19+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-17168000.0
Tetraphase Pharmaceuticals Inc,TTPH,,0001373707,2016.0,Q2,2016-04-01,2016-06-30,2017-08-02 16:06:19+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,36500000.0
Tetraphase Pharmaceuticals Inc,TTPH,,0001373707,2016.0,Q2,2016-04-01,2016-06-30,2017-08-02 16:06:19+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.47
Tetraphase Pharmaceuticals Inc,TTPH,,0001373707,2016.0,Q2,2016-04-01,2016-06-30,2017-08-02 16:06:19+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,36500000.0
Tetraphase Pharmaceuticals Inc,TTPH,,0001373707,2016.0,Q2,2016-04-01,2016-06-30,2017-08-02 16:06:19+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.47
Tetraphase Pharmaceuticals Inc,TTPH,,0001373707,2016.0,Q2,2016-04-01,2016-06-30,2017-08-02 16:06:19+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,36629000.0
Tetraphase Pharmaceuticals Inc,TTPH,,0001373707,2016.0,Q2,2016-04-01,2016-06-30,2017-08-02 16:06:19+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.47
Tetraphase Pharmaceuticals Inc,TTPH,,0001373707,2016.0,Q3,2016-07-01,2016-09-30,2017-11-01 17:19:15+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,850000.0
Tetraphase Pharmaceuticals Inc,TTPH,,0001373707,2016.0,Q3,2016-07-01,2016-09-30,2017-11-01 17:19:15+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,850000.0
Tetraphase Pharmaceuticals Inc,TTPH,,0001373707,2016.0,Q3,2016-07-01,2016-09-30,2017-11-01 17:19:15+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,850000.0
Tetraphase Pharmaceuticals Inc,TTPH,,0001373707,2016.0,Q3,2016-07-01,2016-09-30,2017-11-01 17:19:15+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,4858000.0
Tetraphase Pharmaceuticals Inc,TTPH,,0001373707,2016.0,Q3,2016-07-01,2016-09-30,2017-11-01 17:19:15+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,17190000.0
Tetraphase Pharmaceuticals Inc,TTPH,,0001373707,2016.0,Q3,2016-07-01,2016-09-30,2017-11-01 17:19:15+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,22048000.0
Tetraphase Pharmaceuticals Inc,TTPH,,0001373707,2016.0,Q3,2016-07-01,2016-09-30,2017-11-01 17:19:15+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-21198000.0
Tetraphase Pharmaceuticals Inc,TTPH,,0001373707,2016.0,Q3,2016-07-01,2016-09-30,2017-11-01 17:19:15+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,88000.0
Tetraphase Pharmaceuticals Inc,TTPH,,0001373707,2016.0,Q3,2016-07-01,2016-09-30,2017-11-01 17:19:15+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,88000.0
Tetraphase Pharmaceuticals Inc,TTPH,,0001373707,2016.0,Q3,2016-07-01,2016-09-30,2017-11-01 17:19:15+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-21110000.0
Tetraphase Pharmaceuticals Inc,TTPH,,0001373707,2016.0,Q3,2016-07-01,2016-09-30,2017-11-01 17:19:15+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-21110000.0
Tetraphase Pharmaceuticals Inc,TTPH,,0001373707,2016.0,Q3,2016-07-01,2016-09-30,2017-11-01 17:19:15+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-21110000.0
Tetraphase Pharmaceuticals Inc,TTPH,,0001373707,2016.0,Q3,2016-07-01,2016-09-30,2017-11-01 17:19:15+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-21110000.0
Tetraphase Pharmaceuticals Inc,TTPH,,0001373707,2016.0,Q3,2016-07-01,2016-09-30,2017-11-01 17:19:15+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,36400000.0
Tetraphase Pharmaceuticals Inc,TTPH,,0001373707,2016.0,Q3,2016-07-01,2016-09-30,2017-11-01 17:19:15+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.58
Tetraphase Pharmaceuticals Inc,TTPH,,0001373707,2016.0,Q3,2016-07-01,2016-09-30,2017-11-01 17:19:15+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,36400000.0
Tetraphase Pharmaceuticals Inc,TTPH,,0001373707,2016.0,Q3,2016-07-01,2016-09-30,2017-11-01 17:19:15+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.58
Tetraphase Pharmaceuticals Inc,TTPH,,0001373707,2016.0,Q3,2016-07-01,2016-09-30,2017-11-01 17:19:15+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,36692000.0
Tetraphase Pharmaceuticals Inc,TTPH,,0001373707,2016.0,Q3,2016-07-01,2016-09-30,2017-11-01 17:19:15+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.58
Tetraphase Pharmaceuticals Inc,TTPH,,0001373707,2016.0,Q4,2016-10-01,2016-12-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,1090000.0
Tetraphase Pharmaceuticals Inc,TTPH,,0001373707,2016.0,Q4,2016-10-01,2016-12-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,1090000.0
Tetraphase Pharmaceuticals Inc,TTPH,,0001373707,2016.0,Q4,2016-10-01,2016-12-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,1090000.0
Tetraphase Pharmaceuticals Inc,TTPH,,0001373707,2016.0,Q4,2016-10-01,2016-12-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,4341000.0
Tetraphase Pharmaceuticals Inc,TTPH,,0001373707,2016.0,Q4,2016-10-01,2016-12-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,19305000.0
Tetraphase Pharmaceuticals Inc,TTPH,,0001373707,2016.0,Q4,2016-10-01,2016-12-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,23646000.0
Tetraphase Pharmaceuticals Inc,TTPH,,0001373707,2016.0,Q4,2016-10-01,2016-12-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-22556000.0
Tetraphase Pharmaceuticals Inc,TTPH,,0001373707,2016.0,Q4,2016-10-01,2016-12-31,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,95000.0
Tetraphase Pharmaceuticals Inc,TTPH,,0001373707,2016.0,Q4,2016-10-01,2016-12-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,95000.0
Tetraphase Pharmaceuticals Inc,TTPH,,0001373707,2016.0,Q4,2016-10-01,2016-12-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-22461000.0
Tetraphase Pharmaceuticals Inc,TTPH,,0001373707,2016.0,Q4,2016-10-01,2016-12-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-22461000.0
Tetraphase Pharmaceuticals Inc,TTPH,,0001373707,2016.0,Q4,2016-10-01,2016-12-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-22461000.0
Tetraphase Pharmaceuticals Inc,TTPH,,0001373707,2016.0,Q4,2016-10-01,2016-12-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-22461000.0
Tetraphase Pharmaceuticals Inc,TTPH,,0001373707,2016.0,Q4,2016-10-01,2016-12-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,36700000.0
Tetraphase Pharmaceuticals Inc,TTPH,,0001373707,2016.0,Q4,2016-10-01,2016-12-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.61
Tetraphase Pharmaceuticals Inc,TTPH,,0001373707,2016.0,Q4,2016-10-01,2016-12-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,36700000.0
Tetraphase Pharmaceuticals Inc,TTPH,,0001373707,2016.0,Q4,2016-10-01,2016-12-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.61
Tetraphase Pharmaceuticals Inc,TTPH,,0001373707,2016.0,Q4,2016-10-01,2016-12-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,36704000.0
Tetraphase Pharmaceuticals Inc,TTPH,,0001373707,2016.0,Q4,2016-10-01,2016-12-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.61
Tetraphase Pharmaceuticals Inc,TTPH,,0001373707,2017.0,Q1,2017-01-01,2017-03-31,2018-05-03 16:12:04+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,1485000.0
Tetraphase Pharmaceuticals Inc,TTPH,,0001373707,2017.0,Q1,2017-01-01,2017-03-31,2018-05-03 16:12:04+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,1485000.0
Tetraphase Pharmaceuticals Inc,TTPH,,0001373707,2017.0,Q1,2017-01-01,2017-03-31,2018-05-03 16:12:04+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,1485000.0
Tetraphase Pharmaceuticals Inc,TTPH,,0001373707,2017.0,Q1,2017-01-01,2017-03-31,2018-05-03 16:12:04+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,5133000.0
Tetraphase Pharmaceuticals Inc,TTPH,,0001373707,2017.0,Q1,2017-01-01,2017-03-31,2018-05-03 16:12:04+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,25947000.0
Tetraphase Pharmaceuticals Inc,TTPH,,0001373707,2017.0,Q1,2017-01-01,2017-03-31,2018-05-03 16:12:04+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,31080000.0
Tetraphase Pharmaceuticals Inc,TTPH,,0001373707,2017.0,Q1,2017-01-01,2017-03-31,2018-05-03 16:12:04+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-29595000.0
Tetraphase Pharmaceuticals Inc,TTPH,,0001373707,2017.0,Q1,2017-01-01,2017-03-31,2018-05-03 16:12:04+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,137000.0
Tetraphase Pharmaceuticals Inc,TTPH,,0001373707,2017.0,Q1,2017-01-01,2017-03-31,2018-05-03 16:12:04+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,137000.0
Tetraphase Pharmaceuticals Inc,TTPH,,0001373707,2017.0,Q1,2017-01-01,2017-03-31,2018-05-03 16:12:04+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-29458000.0
Tetraphase Pharmaceuticals Inc,TTPH,,0001373707,2017.0,Q1,2017-01-01,2017-03-31,2018-05-03 16:12:04+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-29458000.0
Tetraphase Pharmaceuticals Inc,TTPH,,0001373707,2017.0,Q1,2017-01-01,2017-03-31,2018-05-03 16:12:04+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-29458000.0
Tetraphase Pharmaceuticals Inc,TTPH,,0001373707,2017.0,Q1,2017-01-01,2017-03-31,2018-05-03 16:12:04+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-29458000.0
Tetraphase Pharmaceuticals Inc,TTPH,,0001373707,2017.0,Q1,2017-01-01,2017-03-31,2018-05-03 16:12:04+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,37300000.0
Tetraphase Pharmaceuticals Inc,TTPH,,0001373707,2017.0,Q1,2017-01-01,2017-03-31,2018-05-03 16:12:04+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.79
Tetraphase Pharmaceuticals Inc,TTPH,,0001373707,2017.0,Q1,2017-01-01,2017-03-31,2018-05-03 16:12:04+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,37300000.0
Tetraphase Pharmaceuticals Inc,TTPH,,0001373707,2017.0,Q1,2017-01-01,2017-03-31,2018-05-03 16:12:04+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.79
Tetraphase Pharmaceuticals Inc,TTPH,,0001373707,2017.0,Q1,2017-01-01,2017-03-31,2018-05-03 16:12:04+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,37093000.0
Tetraphase Pharmaceuticals Inc,TTPH,,0001373707,2017.0,Q1,2017-01-01,2017-03-31,2018-05-03 16:12:04+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.79
Tetraphase Pharmaceuticals Inc,TTPH,,0001373707,2017.0,Q2,2017-04-01,2017-06-30,2018-08-02 16:03:26+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,1586000.0
Tetraphase Pharmaceuticals Inc,TTPH,,0001373707,2017.0,Q2,2017-04-01,2017-06-30,2018-08-02 16:03:26+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,1586000.0
Tetraphase Pharmaceuticals Inc,TTPH,,0001373707,2017.0,Q2,2017-04-01,2017-06-30,2018-08-02 16:03:26+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,1586000.0
Tetraphase Pharmaceuticals Inc,TTPH,,0001373707,2017.0,Q2,2017-04-01,2017-06-30,2018-08-02 16:03:26+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,5065000.0
Tetraphase Pharmaceuticals Inc,TTPH,,0001373707,2017.0,Q2,2017-04-01,2017-06-30,2018-08-02 16:03:26+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,28513000.0
Tetraphase Pharmaceuticals Inc,TTPH,,0001373707,2017.0,Q2,2017-04-01,2017-06-30,2018-08-02 16:03:26+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,33578000.0
Tetraphase Pharmaceuticals Inc,TTPH,,0001373707,2017.0,Q2,2017-04-01,2017-06-30,2018-08-02 16:03:26+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-31992000.0
Tetraphase Pharmaceuticals Inc,TTPH,,0001373707,2017.0,Q2,2017-04-01,2017-06-30,2018-08-02 16:03:26+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,181000.0
Tetraphase Pharmaceuticals Inc,TTPH,,0001373707,2017.0,Q2,2017-04-01,2017-06-30,2018-08-02 16:03:26+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,181000.0
Tetraphase Pharmaceuticals Inc,TTPH,,0001373707,2017.0,Q2,2017-04-01,2017-06-30,2018-08-02 16:03:26+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-31811000.0
Tetraphase Pharmaceuticals Inc,TTPH,,0001373707,2017.0,Q2,2017-04-01,2017-06-30,2018-08-02 16:03:26+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-31811000.0
Tetraphase Pharmaceuticals Inc,TTPH,,0001373707,2017.0,Q2,2017-04-01,2017-06-30,2018-08-02 16:03:26+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-31811000.0
Tetraphase Pharmaceuticals Inc,TTPH,,0001373707,2017.0,Q2,2017-04-01,2017-06-30,2018-08-02 16:03:26+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-31811000.0
Tetraphase Pharmaceuticals Inc,TTPH,,0001373707,2017.0,Q2,2017-04-01,2017-06-30,2018-08-02 16:03:26+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,38300000.0
Tetraphase Pharmaceuticals Inc,TTPH,,0001373707,2017.0,Q2,2017-04-01,2017-06-30,2018-08-02 16:03:26+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.83
Tetraphase Pharmaceuticals Inc,TTPH,,0001373707,2017.0,Q2,2017-04-01,2017-06-30,2018-08-02 16:03:26+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,38300000.0
Tetraphase Pharmaceuticals Inc,TTPH,,0001373707,2017.0,Q2,2017-04-01,2017-06-30,2018-08-02 16:03:26+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.83
Tetraphase Pharmaceuticals Inc,TTPH,,0001373707,2017.0,Q2,2017-04-01,2017-06-30,2018-08-02 16:03:26+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,38273000.0
Tetraphase Pharmaceuticals Inc,TTPH,,0001373707,2017.0,Q2,2017-04-01,2017-06-30,2018-08-02 16:03:26+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.83
Tetraphase Pharmaceuticals Inc,TTPH,,0001373707,2017.0,Q3,2017-07-01,2017-09-30,2018-11-08 18:52:21+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,4067000.0
Tetraphase Pharmaceuticals Inc,TTPH,,0001373707,2017.0,Q3,2017-07-01,2017-09-30,2018-11-08 18:52:21+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,4067000.0
Tetraphase Pharmaceuticals Inc,TTPH,,0001373707,2017.0,Q3,2017-07-01,2017-09-30,2018-11-08 18:52:21+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,4067000.0
Tetraphase Pharmaceuticals Inc,TTPH,,0001373707,2017.0,Q3,2017-07-01,2017-09-30,2018-11-08 18:52:21+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,5600000.0
Tetraphase Pharmaceuticals Inc,TTPH,,0001373707,2017.0,Q3,2017-07-01,2017-09-30,2018-11-08 18:52:21+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,28777000.0
Tetraphase Pharmaceuticals Inc,TTPH,,0001373707,2017.0,Q3,2017-07-01,2017-09-30,2018-11-08 18:52:21+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,34377000.0
Tetraphase Pharmaceuticals Inc,TTPH,,0001373707,2017.0,Q3,2017-07-01,2017-09-30,2018-11-08 18:52:21+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-30310000.0
Tetraphase Pharmaceuticals Inc,TTPH,,0001373707,2017.0,Q3,2017-07-01,2017-09-30,2018-11-08 18:52:21+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,302000.0
Tetraphase Pharmaceuticals Inc,TTPH,,0001373707,2017.0,Q3,2017-07-01,2017-09-30,2018-11-08 18:52:21+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,302000.0
Tetraphase Pharmaceuticals Inc,TTPH,,0001373707,2017.0,Q3,2017-07-01,2017-09-30,2018-11-08 18:52:21+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-30008000.0
Tetraphase Pharmaceuticals Inc,TTPH,,0001373707,2017.0,Q3,2017-07-01,2017-09-30,2018-11-08 18:52:21+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-30008000.0
Tetraphase Pharmaceuticals Inc,TTPH,,0001373707,2017.0,Q3,2017-07-01,2017-09-30,2018-11-08 18:52:21+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-30008000.0
Tetraphase Pharmaceuticals Inc,TTPH,,0001373707,2017.0,Q3,2017-07-01,2017-09-30,2018-11-08 18:52:21+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-30008000.0
Tetraphase Pharmaceuticals Inc,TTPH,,0001373707,2017.0,Q3,2017-07-01,2017-09-30,2018-11-08 18:52:21+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,47600000.0
Tetraphase Pharmaceuticals Inc,TTPH,,0001373707,2017.0,Q3,2017-07-01,2017-09-30,2018-11-08 18:52:21+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.63
Tetraphase Pharmaceuticals Inc,TTPH,,0001373707,2017.0,Q3,2017-07-01,2017-09-30,2018-11-08 18:52:21+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,47600000.0
Tetraphase Pharmaceuticals Inc,TTPH,,0001373707,2017.0,Q3,2017-07-01,2017-09-30,2018-11-08 18:52:21+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.63
Tetraphase Pharmaceuticals Inc,TTPH,,0001373707,2017.0,Q3,2017-07-01,2017-09-30,2018-11-08 18:52:21+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,47347000.0
Tetraphase Pharmaceuticals Inc,TTPH,,0001373707,2017.0,Q3,2017-07-01,2017-09-30,2018-11-08 18:52:21+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.63
Tetraphase Pharmaceuticals Inc,TTPH,,0001373707,2017.0,Q4,2017-10-01,2017-12-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,2528000.0
Tetraphase Pharmaceuticals Inc,TTPH,,0001373707,2017.0,Q4,2017-10-01,2017-12-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,2528000.0
Tetraphase Pharmaceuticals Inc,TTPH,,0001373707,2017.0,Q4,2017-10-01,2017-12-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,2528000.0
Tetraphase Pharmaceuticals Inc,TTPH,,0001373707,2017.0,Q4,2017-10-01,2017-12-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,7877000.0
Tetraphase Pharmaceuticals Inc,TTPH,,0001373707,2017.0,Q4,2017-10-01,2017-12-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,18469000.0
Tetraphase Pharmaceuticals Inc,TTPH,,0001373707,2017.0,Q4,2017-10-01,2017-12-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,26346000.0
Tetraphase Pharmaceuticals Inc,TTPH,,0001373707,2017.0,Q4,2017-10-01,2017-12-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-23818000.0
Tetraphase Pharmaceuticals Inc,TTPH,,0001373707,2017.0,Q4,2017-10-01,2017-12-31,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,963000.0
Tetraphase Pharmaceuticals Inc,TTPH,,0001373707,2017.0,Q4,2017-10-01,2017-12-31,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-620000.0
Tetraphase Pharmaceuticals Inc,TTPH,,0001373707,2017.0,Q4,2017-10-01,2017-12-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,343000.0
Tetraphase Pharmaceuticals Inc,TTPH,,0001373707,2017.0,Q4,2017-10-01,2017-12-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-23475000.0
Tetraphase Pharmaceuticals Inc,TTPH,,0001373707,2017.0,Q4,2017-10-01,2017-12-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-23475000.0
Tetraphase Pharmaceuticals Inc,TTPH,,0001373707,2017.0,Q4,2017-10-01,2017-12-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-23475000.0
Tetraphase Pharmaceuticals Inc,TTPH,,0001373707,2017.0,Q4,2017-10-01,2017-12-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-23475000.0
Tetraphase Pharmaceuticals Inc,TTPH,,0001373707,2017.0,Q4,2017-10-01,2017-12-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,43600000.0
Tetraphase Pharmaceuticals Inc,TTPH,,0001373707,2017.0,Q4,2017-10-01,2017-12-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.54
Tetraphase Pharmaceuticals Inc,TTPH,,0001373707,2017.0,Q4,2017-10-01,2017-12-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,43600000.0
Tetraphase Pharmaceuticals Inc,TTPH,,0001373707,2017.0,Q4,2017-10-01,2017-12-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.54
Tetraphase Pharmaceuticals Inc,TTPH,,0001373707,2017.0,Q4,2017-10-01,2017-12-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,43582000.0
Tetraphase Pharmaceuticals Inc,TTPH,,0001373707,2017.0,Q4,2017-10-01,2017-12-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.54
Tetraphase Pharmaceuticals Inc,TTPH,,0001373707,2018.0,Q1,2018-01-01,2018-03-31,2019-05-08 17:17:10+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,1891000.0
Tetraphase Pharmaceuticals Inc,TTPH,,0001373707,2018.0,Q1,2018-01-01,2018-03-31,2019-05-08 17:17:10+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,1891000.0
Tetraphase Pharmaceuticals Inc,TTPH,,0001373707,2018.0,Q1,2018-01-01,2018-03-31,2019-05-08 17:17:10+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,1891000.0
Tetraphase Pharmaceuticals Inc,TTPH,,0001373707,2018.0,Q1,2018-01-01,2018-03-31,2019-05-08 17:17:10+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,5705000.0
Tetraphase Pharmaceuticals Inc,TTPH,,0001373707,2018.0,Q1,2018-01-01,2018-03-31,2019-05-08 17:17:10+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,18127000.0
Tetraphase Pharmaceuticals Inc,TTPH,,0001373707,2018.0,Q1,2018-01-01,2018-03-31,2019-05-08 17:17:10+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,23832000.0
Tetraphase Pharmaceuticals Inc,TTPH,,0001373707,2018.0,Q1,2018-01-01,2018-03-31,2019-05-08 17:17:10+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-21941000.0
Tetraphase Pharmaceuticals Inc,TTPH,,0001373707,2018.0,Q1,2018-01-01,2018-03-31,2019-05-08 17:17:10+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,365000.0
Tetraphase Pharmaceuticals Inc,TTPH,,0001373707,2018.0,Q1,2018-01-01,2018-03-31,2019-05-08 17:17:10+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,365000.0
Tetraphase Pharmaceuticals Inc,TTPH,,0001373707,2018.0,Q1,2018-01-01,2018-03-31,2019-05-08 17:17:10+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-21576000.0
Tetraphase Pharmaceuticals Inc,TTPH,,0001373707,2018.0,Q1,2018-01-01,2018-03-31,2019-05-08 17:17:10+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-21576000.0
Tetraphase Pharmaceuticals Inc,TTPH,,0001373707,2018.0,Q1,2018-01-01,2018-03-31,2019-05-08 17:17:10+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-21576000.0
Tetraphase Pharmaceuticals Inc,TTPH,,0001373707,2018.0,Q1,2018-01-01,2018-03-31,2019-05-08 17:17:10+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-21576000.0
Tetraphase Pharmaceuticals Inc,TTPH,,0001373707,2018.0,Q1,2018-01-01,2018-03-31,2019-05-08 17:17:10+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,51400000.0
Tetraphase Pharmaceuticals Inc,TTPH,,0001373707,2018.0,Q1,2018-01-01,2018-03-31,2019-05-08 17:17:10+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.42
Tetraphase Pharmaceuticals Inc,TTPH,,0001373707,2018.0,Q1,2018-01-01,2018-03-31,2019-05-08 17:17:10+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,51400000.0
Tetraphase Pharmaceuticals Inc,TTPH,,0001373707,2018.0,Q1,2018-01-01,2018-03-31,2019-05-08 17:17:10+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.42
Tetraphase Pharmaceuticals Inc,TTPH,,0001373707,2018.0,Q1,2018-01-01,2018-03-31,2019-05-08 17:17:10+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,51601000.0
Tetraphase Pharmaceuticals Inc,TTPH,,0001373707,2018.0,Q1,2018-01-01,2018-03-31,2019-05-08 17:17:10+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.42
Tetraphase Pharmaceuticals Inc,TTPH,,0001373707,2018.0,Q2,2018-04-01,2018-06-30,2019-08-08 17:31:30+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,11579000.0
Tetraphase Pharmaceuticals Inc,TTPH,,0001373707,2018.0,Q2,2018-04-01,2018-06-30,2019-08-08 17:31:30+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,11579000.0
Tetraphase Pharmaceuticals Inc,TTPH,,0001373707,2018.0,Q2,2018-04-01,2018-06-30,2019-08-08 17:31:30+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,11579000.0
Tetraphase Pharmaceuticals Inc,TTPH,,0001373707,2018.0,Q2,2018-04-01,2018-06-30,2019-08-08 17:31:30+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,7165000.0
Tetraphase Pharmaceuticals Inc,TTPH,,0001373707,2018.0,Q2,2018-04-01,2018-06-30,2019-08-08 17:31:30+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,14370000.0
Tetraphase Pharmaceuticals Inc,TTPH,,0001373707,2018.0,Q2,2018-04-01,2018-06-30,2019-08-08 17:31:30+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,21535000.0
Tetraphase Pharmaceuticals Inc,TTPH,,0001373707,2018.0,Q2,2018-04-01,2018-06-30,2019-08-08 17:31:30+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-9956000.0
Tetraphase Pharmaceuticals Inc,TTPH,,0001373707,2018.0,Q2,2018-04-01,2018-06-30,2019-08-08 17:31:30+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,413000.0
Tetraphase Pharmaceuticals Inc,TTPH,,0001373707,2018.0,Q2,2018-04-01,2018-06-30,2019-08-08 17:31:30+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,413000.0
Tetraphase Pharmaceuticals Inc,TTPH,,0001373707,2018.0,Q2,2018-04-01,2018-06-30,2019-08-08 17:31:30+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-9543000.0
Tetraphase Pharmaceuticals Inc,TTPH,,0001373707,2018.0,Q2,2018-04-01,2018-06-30,2019-08-08 17:31:30+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-9543000.0
Tetraphase Pharmaceuticals Inc,TTPH,,0001373707,2018.0,Q2,2018-04-01,2018-06-30,2019-08-08 17:31:30+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-9543000.0
Tetraphase Pharmaceuticals Inc,TTPH,,0001373707,2018.0,Q2,2018-04-01,2018-06-30,2019-08-08 17:31:30+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-9543000.0
Tetraphase Pharmaceuticals Inc,TTPH,,0001373707,2018.0,Q2,2018-04-01,2018-06-30,2019-08-08 17:31:30+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,53000000.0
Tetraphase Pharmaceuticals Inc,TTPH,,0001373707,2018.0,Q2,2018-04-01,2018-06-30,2019-08-08 17:31:30+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.18
Tetraphase Pharmaceuticals Inc,TTPH,,0001373707,2018.0,Q2,2018-04-01,2018-06-30,2019-08-08 17:31:30+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,53000000.0
Tetraphase Pharmaceuticals Inc,TTPH,,0001373707,2018.0,Q2,2018-04-01,2018-06-30,2019-08-08 17:31:30+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.18
Tetraphase Pharmaceuticals Inc,TTPH,,0001373707,2018.0,Q2,2018-04-01,2018-06-30,2019-08-08 17:31:30+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,51839000.0
Tetraphase Pharmaceuticals Inc,TTPH,,0001373707,2018.0,Q2,2018-04-01,2018-06-30,2019-08-08 17:31:30+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.18
Tetraphase Pharmaceuticals Inc,TTPH,,0001373707,2018.0,Q3,2018-07-01,2018-09-30,2019-11-12 17:03:55+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,1151000.0
Tetraphase Pharmaceuticals Inc,TTPH,,0001373707,2018.0,Q3,2018-07-01,2018-09-30,2019-11-12 17:03:55+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,1151000.0
Tetraphase Pharmaceuticals Inc,TTPH,,0001373707,2018.0,Q3,2018-07-01,2018-09-30,2019-11-12 17:03:55+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,1151000.0
Tetraphase Pharmaceuticals Inc,TTPH,,0001373707,2018.0,Q3,2018-07-01,2018-09-30,2019-11-12 17:03:55+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,9481000.0
Tetraphase Pharmaceuticals Inc,TTPH,,0001373707,2018.0,Q3,2018-07-01,2018-09-30,2019-11-12 17:03:55+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,11665000.0
Tetraphase Pharmaceuticals Inc,TTPH,,0001373707,2018.0,Q3,2018-07-01,2018-09-30,2019-11-12 17:03:55+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,21146000.0
Tetraphase Pharmaceuticals Inc,TTPH,,0001373707,2018.0,Q3,2018-07-01,2018-09-30,2019-11-12 17:03:55+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-19995000.0
Tetraphase Pharmaceuticals Inc,TTPH,,0001373707,2018.0,Q3,2018-07-01,2018-09-30,2019-11-12 17:03:55+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,437000.0
Tetraphase Pharmaceuticals Inc,TTPH,,0001373707,2018.0,Q3,2018-07-01,2018-09-30,2019-11-12 17:03:55+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,437000.0
Tetraphase Pharmaceuticals Inc,TTPH,,0001373707,2018.0,Q3,2018-07-01,2018-09-30,2019-11-12 17:03:55+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-19558000.0
Tetraphase Pharmaceuticals Inc,TTPH,,0001373707,2018.0,Q3,2018-07-01,2018-09-30,2019-11-12 17:03:55+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-19558000.0
Tetraphase Pharmaceuticals Inc,TTPH,,0001373707,2018.0,Q3,2018-07-01,2018-09-30,2019-11-12 17:03:55+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-19558000.0
Tetraphase Pharmaceuticals Inc,TTPH,,0001373707,2018.0,Q3,2018-07-01,2018-09-30,2019-11-12 17:03:55+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-19558000.0
Tetraphase Pharmaceuticals Inc,TTPH,,0001373707,2018.0,Q3,2018-07-01,2018-09-30,2019-11-12 17:03:55+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,2600000.0
Tetraphase Pharmaceuticals Inc,TTPH,,0001373707,2018.0,Q3,2018-07-01,2018-09-30,2019-11-12 17:03:55+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-7.39
Tetraphase Pharmaceuticals Inc,TTPH,,0001373707,2018.0,Q3,2018-07-01,2018-09-30,2019-11-12 17:03:55+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,2600000.0
Tetraphase Pharmaceuticals Inc,TTPH,,0001373707,2018.0,Q3,2018-07-01,2018-09-30,2019-11-12 17:03:55+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-7.39
Tetraphase Pharmaceuticals Inc,TTPH,,0001373707,2018.0,Q3,2018-07-01,2018-09-30,2019-11-12 17:03:55+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,2647000.0
Tetraphase Pharmaceuticals Inc,TTPH,,0001373707,2018.0,Q3,2018-07-01,2018-09-30,2019-11-12 17:03:55+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-7.39
Tetraphase Pharmaceuticals Inc,TTPH,,0001373707,2018.0,Q4,2018-10-01,2018-12-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,4283000.0
Tetraphase Pharmaceuticals Inc,TTPH,,0001373707,2018.0,Q4,2018-10-01,2018-12-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,4283000.0
Tetraphase Pharmaceuticals Inc,TTPH,,0001373707,2018.0,Q4,2018-10-01,2018-12-31,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,228000.0
Tetraphase Pharmaceuticals Inc,TTPH,,0001373707,2018.0,Q4,2018-10-01,2018-12-31,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,228000.0
Tetraphase Pharmaceuticals Inc,TTPH,,0001373707,2018.0,Q4,2018-10-01,2018-12-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,4055000.0
Tetraphase Pharmaceuticals Inc,TTPH,,0001373707,2018.0,Q4,2018-10-01,2018-12-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,14727000.0
Tetraphase Pharmaceuticals Inc,TTPH,,0001373707,2018.0,Q4,2018-10-01,2018-12-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,10717000.0
Tetraphase Pharmaceuticals Inc,TTPH,,0001373707,2018.0,Q4,2018-10-01,2018-12-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,25444000.0
Tetraphase Pharmaceuticals Inc,TTPH,,0001373707,2018.0,Q4,2018-10-01,2018-12-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-21389000.0
Tetraphase Pharmaceuticals Inc,TTPH,,0001373707,2018.0,Q4,2018-10-01,2018-12-31,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,624000.0
Tetraphase Pharmaceuticals Inc,TTPH,,0001373707,2018.0,Q4,2018-10-01,2018-12-31,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,532000.0
Tetraphase Pharmaceuticals Inc,TTPH,,0001373707,2018.0,Q4,2018-10-01,2018-12-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-92000.0
Tetraphase Pharmaceuticals Inc,TTPH,,0001373707,2018.0,Q4,2018-10-01,2018-12-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-21481000.0
Tetraphase Pharmaceuticals Inc,TTPH,,0001373707,2018.0,Q4,2018-10-01,2018-12-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-21481000.0
Tetraphase Pharmaceuticals Inc,TTPH,,0001373707,2018.0,Q4,2018-10-01,2018-12-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-21481000.0
Tetraphase Pharmaceuticals Inc,TTPH,,0001373707,2018.0,Q4,2018-10-01,2018-12-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-21481000.0
Tetraphase Pharmaceuticals Inc,TTPH,,0001373707,2018.0,Q4,2018-10-01,2018-12-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,2600000.0
Tetraphase Pharmaceuticals Inc,TTPH,,0001373707,2018.0,Q4,2018-10-01,2018-12-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,-8.26
Tetraphase Pharmaceuticals Inc,TTPH,,0001373707,2018.0,Q4,2018-10-01,2018-12-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,2600000.0
Tetraphase Pharmaceuticals Inc,TTPH,,0001373707,2018.0,Q4,2018-10-01,2018-12-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-8.26
Tetraphase Pharmaceuticals Inc,TTPH,,0001373707,2018.0,Q4,2018-10-01,2018-12-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,2626000.0
Tetraphase Pharmaceuticals Inc,TTPH,,0001373707,2018.0,Q4,2018-10-01,2018-12-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-8.26
Tetraphase Pharmaceuticals Inc,TTPH,,0001373707,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 16:03:01+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,1273000.0
Tetraphase Pharmaceuticals Inc,TTPH,,0001373707,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 16:03:01+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,1273000.0
Tetraphase Pharmaceuticals Inc,TTPH,,0001373707,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 16:03:01+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,262000.0
Tetraphase Pharmaceuticals Inc,TTPH,,0001373707,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 16:03:01+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,262000.0
Tetraphase Pharmaceuticals Inc,TTPH,,0001373707,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 16:03:01+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,1011000.0
Tetraphase Pharmaceuticals Inc,TTPH,,0001373707,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 16:03:01+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,13314000.0
Tetraphase Pharmaceuticals Inc,TTPH,,0001373707,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 16:03:01+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,6737000.0
Tetraphase Pharmaceuticals Inc,TTPH,,0001373707,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 16:03:01+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,20051000.0
Tetraphase Pharmaceuticals Inc,TTPH,,0001373707,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 16:03:01+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-19040000.0
Tetraphase Pharmaceuticals Inc,TTPH,,0001373707,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 16:03:01+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,955000.0
Tetraphase Pharmaceuticals Inc,TTPH,,0001373707,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 16:03:01+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,507000.0
Tetraphase Pharmaceuticals Inc,TTPH,,0001373707,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 16:03:01+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-448000.0
Tetraphase Pharmaceuticals Inc,TTPH,,0001373707,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 16:03:01+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-19488000.0
Tetraphase Pharmaceuticals Inc,TTPH,,0001373707,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 16:03:01+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-19488000.0
Tetraphase Pharmaceuticals Inc,TTPH,,0001373707,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 16:03:01+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-19488000.0
Tetraphase Pharmaceuticals Inc,TTPH,,0001373707,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 16:03:01+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-19488000.0
Tetraphase Pharmaceuticals Inc,TTPH,,0001373707,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 16:03:01+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,2700000.0
Tetraphase Pharmaceuticals Inc,TTPH,,0001373707,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 16:03:01+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-7.25
Tetraphase Pharmaceuticals Inc,TTPH,,0001373707,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 16:03:01+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,2700000.0
Tetraphase Pharmaceuticals Inc,TTPH,,0001373707,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 16:03:01+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-7.25
Tetraphase Pharmaceuticals Inc,TTPH,,0001373707,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 16:03:01+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,2687000.0
Tetraphase Pharmaceuticals Inc,TTPH,,0001373707,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 16:03:01+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-7.25
Tetraphase Pharmaceuticals Inc,TTPH,,0001373707,2019.0,Q2,2019-04-01,2019-06-30,2019-08-08 17:31:30+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,1073000.0
Tetraphase Pharmaceuticals Inc,TTPH,,0001373707,2019.0,Q2,2019-04-01,2019-06-30,2019-08-08 17:31:30+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,1073000.0
Tetraphase Pharmaceuticals Inc,TTPH,,0001373707,2019.0,Q2,2019-04-01,2019-06-30,2019-08-08 17:31:30+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,406000.0
Tetraphase Pharmaceuticals Inc,TTPH,,0001373707,2019.0,Q2,2019-04-01,2019-06-30,2019-08-08 17:31:30+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,406000.0
Tetraphase Pharmaceuticals Inc,TTPH,,0001373707,2019.0,Q2,2019-04-01,2019-06-30,2019-08-08 17:31:30+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,667000.0
Tetraphase Pharmaceuticals Inc,TTPH,,0001373707,2019.0,Q2,2019-04-01,2019-06-30,2019-08-08 17:31:30+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,15113000.0
Tetraphase Pharmaceuticals Inc,TTPH,,0001373707,2019.0,Q2,2019-04-01,2019-06-30,2019-08-08 17:31:30+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,8166000.0
Tetraphase Pharmaceuticals Inc,TTPH,,0001373707,2019.0,Q2,2019-04-01,2019-06-30,2019-08-08 17:31:30+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,23279000.0
Tetraphase Pharmaceuticals Inc,TTPH,,0001373707,2019.0,Q2,2019-04-01,2019-06-30,2019-08-08 17:31:30+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-22612000.0
Tetraphase Pharmaceuticals Inc,TTPH,,0001373707,2019.0,Q2,2019-04-01,2019-06-30,2019-08-08 17:31:30+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,975000.0
Tetraphase Pharmaceuticals Inc,TTPH,,0001373707,2019.0,Q2,2019-04-01,2019-06-30,2019-08-08 17:31:30+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,416000.0
Tetraphase Pharmaceuticals Inc,TTPH,,0001373707,2019.0,Q2,2019-04-01,2019-06-30,2019-08-08 17:31:30+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,250000.0
Tetraphase Pharmaceuticals Inc,TTPH,,0001373707,2019.0,Q2,2019-04-01,2019-06-30,2019-08-08 17:31:30+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-309000.0
Tetraphase Pharmaceuticals Inc,TTPH,,0001373707,2019.0,Q2,2019-04-01,2019-06-30,2019-08-08 17:31:30+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-22921000.0
Tetraphase Pharmaceuticals Inc,TTPH,,0001373707,2019.0,Q2,2019-04-01,2019-06-30,2019-08-08 17:31:30+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-22921000.0
Tetraphase Pharmaceuticals Inc,TTPH,,0001373707,2019.0,Q2,2019-04-01,2019-06-30,2019-08-08 17:31:30+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-22921000.0
Tetraphase Pharmaceuticals Inc,TTPH,,0001373707,2019.0,Q2,2019-04-01,2019-06-30,2019-08-08 17:31:30+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-22921000.0
Tetraphase Pharmaceuticals Inc,TTPH,,0001373707,2019.0,Q2,2019-04-01,2019-06-30,2019-08-08 17:31:30+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,54600000.0
Tetraphase Pharmaceuticals Inc,TTPH,,0001373707,2019.0,Q2,2019-04-01,2019-06-30,2019-08-08 17:31:30+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.42
Tetraphase Pharmaceuticals Inc,TTPH,,0001373707,2019.0,Q2,2019-04-01,2019-06-30,2019-08-08 17:31:30+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,54600000.0
Tetraphase Pharmaceuticals Inc,TTPH,,0001373707,2019.0,Q2,2019-04-01,2019-06-30,2019-08-08 17:31:30+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.42
Tetraphase Pharmaceuticals Inc,TTPH,,0001373707,2019.0,Q2,2019-04-01,2019-06-30,2019-08-08 17:31:30+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,54274000.0
Tetraphase Pharmaceuticals Inc,TTPH,,0001373707,2019.0,Q2,2019-04-01,2019-06-30,2019-08-08 17:31:30+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.42
Tetraphase Pharmaceuticals Inc,TTPH,,0001373707,2019.0,Q3,2019-07-01,2019-09-30,2019-11-12 17:03:55+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,3340000.0
Tetraphase Pharmaceuticals Inc,TTPH,,0001373707,2019.0,Q3,2019-07-01,2019-09-30,2019-11-12 17:03:55+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,3340000.0
Tetraphase Pharmaceuticals Inc,TTPH,,0001373707,2019.0,Q3,2019-07-01,2019-09-30,2019-11-12 17:03:55+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,980000.0
Tetraphase Pharmaceuticals Inc,TTPH,,0001373707,2019.0,Q3,2019-07-01,2019-09-30,2019-11-12 17:03:55+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,980000.0
Tetraphase Pharmaceuticals Inc,TTPH,,0001373707,2019.0,Q3,2019-07-01,2019-09-30,2019-11-12 17:03:55+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,2360000.0
Tetraphase Pharmaceuticals Inc,TTPH,,0001373707,2019.0,Q3,2019-07-01,2019-09-30,2019-11-12 17:03:55+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,11350000.0
Tetraphase Pharmaceuticals Inc,TTPH,,0001373707,2019.0,Q3,2019-07-01,2019-09-30,2019-11-12 17:03:55+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,5348000.0
Tetraphase Pharmaceuticals Inc,TTPH,,0001373707,2019.0,Q3,2019-07-01,2019-09-30,2019-11-12 17:03:55+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,16698000.0
Tetraphase Pharmaceuticals Inc,TTPH,,0001373707,2019.0,Q3,2019-07-01,2019-09-30,2019-11-12 17:03:55+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-14338000.0
Tetraphase Pharmaceuticals Inc,TTPH,,0001373707,2019.0,Q3,2019-07-01,2019-09-30,2019-11-12 17:03:55+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,2218000.0
Tetraphase Pharmaceuticals Inc,TTPH,,0001373707,2019.0,Q3,2019-07-01,2019-09-30,2019-11-12 17:03:55+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,252000.0
Tetraphase Pharmaceuticals Inc,TTPH,,0001373707,2019.0,Q3,2019-07-01,2019-09-30,2019-11-12 17:03:55+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-1966000.0
Tetraphase Pharmaceuticals Inc,TTPH,,0001373707,2019.0,Q3,2019-07-01,2019-09-30,2019-11-12 17:03:55+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-16304000.0
Tetraphase Pharmaceuticals Inc,TTPH,,0001373707,2019.0,Q3,2019-07-01,2019-09-30,2019-11-12 17:03:55+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-16304000.0
Tetraphase Pharmaceuticals Inc,TTPH,,0001373707,2019.0,Q3,2019-07-01,2019-09-30,2019-11-12 17:03:55+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-16304000.0
Tetraphase Pharmaceuticals Inc,TTPH,,0001373707,2019.0,Q3,2019-07-01,2019-09-30,2019-11-12 17:03:55+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-16304000.0
Tetraphase Pharmaceuticals Inc,TTPH,,0001373707,2019.0,Q3,2019-07-01,2019-09-30,2019-11-12 17:03:55+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,2700000.0
Tetraphase Pharmaceuticals Inc,TTPH,,0001373707,2019.0,Q3,2019-07-01,2019-09-30,2019-11-12 17:03:55+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-6.0
Tetraphase Pharmaceuticals Inc,TTPH,,0001373707,2019.0,Q3,2019-07-01,2019-09-30,2019-11-12 17:03:55+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,2700000.0
Tetraphase Pharmaceuticals Inc,TTPH,,0001373707,2019.0,Q3,2019-07-01,2019-09-30,2019-11-12 17:03:55+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-6.0
Tetraphase Pharmaceuticals Inc,TTPH,,0001373707,2019.0,Q3,2019-07-01,2019-09-30,2019-11-12 17:03:55+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,2716000.0
Tetraphase Pharmaceuticals Inc,TTPH,,0001373707,2019.0,Q3,2019-07-01,2019-09-30,2019-11-12 17:03:55+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-6.0
Tetraphase Pharmaceuticals Inc,TTPH,,0001373707,2019.0,Q4,2019-10-01,2019-12-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,1690000.0
Tetraphase Pharmaceuticals Inc,TTPH,,0001373707,2019.0,Q4,2019-10-01,2019-12-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,1690000.0
Tetraphase Pharmaceuticals Inc,TTPH,,0001373707,2019.0,Q4,2019-10-01,2019-12-31,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,1432000.0
Tetraphase Pharmaceuticals Inc,TTPH,,0001373707,2019.0,Q4,2019-10-01,2019-12-31,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,1432000.0
Tetraphase Pharmaceuticals Inc,TTPH,,0001373707,2019.0,Q4,2019-10-01,2019-12-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,258000.0
Tetraphase Pharmaceuticals Inc,TTPH,,0001373707,2019.0,Q4,2019-10-01,2019-12-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,9266000.0
Tetraphase Pharmaceuticals Inc,TTPH,,0001373707,2019.0,Q4,2019-10-01,2019-12-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,2534000.0
Tetraphase Pharmaceuticals Inc,TTPH,,0001373707,2019.0,Q4,2019-10-01,2019-12-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,11800000.0
Tetraphase Pharmaceuticals Inc,TTPH,,0001373707,2019.0,Q4,2019-10-01,2019-12-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-11542000.0
Tetraphase Pharmaceuticals Inc,TTPH,,0001373707,2019.0,Q4,2019-10-01,2019-12-31,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,87000.0
Tetraphase Pharmaceuticals Inc,TTPH,,0001373707,2019.0,Q4,2019-10-01,2019-12-31,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,83000.0
Tetraphase Pharmaceuticals Inc,TTPH,,0001373707,2019.0,Q4,2019-10-01,2019-12-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,170000.0
Tetraphase Pharmaceuticals Inc,TTPH,,0001373707,2019.0,Q4,2019-10-01,2019-12-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-11372000.0
Tetraphase Pharmaceuticals Inc,TTPH,,0001373707,2019.0,Q4,2019-10-01,2019-12-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-11372000.0
Tetraphase Pharmaceuticals Inc,TTPH,,0001373707,2019.0,Q4,2019-10-01,2019-12-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-11372000.0
Tetraphase Pharmaceuticals Inc,TTPH,,0001373707,2019.0,Q4,2019-10-01,2019-12-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-11372000.0
Tetraphase Pharmaceuticals Inc,TTPH,,0001373707,2019.0,Q4,2019-10-01,2019-12-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,3100000.0
Tetraphase Pharmaceuticals Inc,TTPH,,0001373707,2019.0,Q4,2019-10-01,2019-12-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,-3.67
Tetraphase Pharmaceuticals Inc,TTPH,,0001373707,2019.0,Q4,2019-10-01,2019-12-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,3100000.0
Tetraphase Pharmaceuticals Inc,TTPH,,0001373707,2019.0,Q4,2019-10-01,2019-12-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-3.67
Tetraphase Pharmaceuticals Inc,TTPH,,0001373707,2019.0,Q4,2019-10-01,2019-12-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,3067000.0
Tetraphase Pharmaceuticals Inc,TTPH,,0001373707,2019.0,Q4,2019-10-01,2019-12-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-3.67
